text,entities,truth,pred,meta,f1,pred_text,truth_text,correct
"However , the components of the NF-kappaB complexes were different in monocytes and B cells , because p50 is part of the NF-kappaB complex induced by CD40 triggering in both monocytes and B cells , whereas p65 was only induced in B cells . In contrast , although the Janus kinase 3 tyrosine kinase was associated with CD40 molecules in both monocytes and resting B cells , Janus kinase 3 phosphorylation induction was observed only in CD40-activated monocytes , with subsequent induction of STAT5a DNA binding activity in the nucleus .","['NF-kappaB complexes', 'monocytes', 'p50', 'NF-kappaB complex', 'CD40', 'monocytes', 'B cells', 'p65', 'B cells', 'Janus kinase 3 tyrosine kinase', 'CD40', 'monocytes', 'resting B cells', 'Janus kinase 3', 'CD40-activated monocytes', 'STAT5a']","['O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O', 'O', 'O', 'B-cell_type', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'B-cell_type', 'O', 'B-cell_type', 'I-cell_type', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'I-protein', 'I-protein', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'B-cell_type', 'O', 'B-cell_type', 'I-cell_type', 'I-cell_type', 'O', 'B-protein', 'I-protein', 'I-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_line', 'I-cell_line', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['I-cell_type', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O', 'O', 'O', 'B-cell_type', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'I-protein', 'I-protein', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'I-protein', 'O', 'O', 'O', 'B-cell_type']","1. NF-kappaB complexes | True | they are protein complexes (protein).
2. monocytes | True | this is a type of cell (cell_type).
3. B cells | True | this is a type of cell (cell_type).
4. p50 | True | this is a subunit of NF-kappaB, so it is considered a protein (protein).
5. CD40 | True | this is a co-stimulatory protein, so it is considered a protein (protein).
6. p65 | True | this is another subunit of NF-kappaB, so it is considered a protein (protein).
7. Janus kinase 3 tyrosine kinase | True | It is considered a protein, more specifically a kinase (protein).
8. CD40 molecules | True | CD40 is a protein, so its molecules are considered protein entities (protein).
9. Janus kinase 3 phosphorylation induction | False | This is a process, not a protein, DNA, RNA, Cell Type or Cell Line.
10. STAT5a DNA binding activity | True | STAT5a is a protein, so it is considered a protein even in the context of 'binding activity' (protein).
11. nucleus | False | which is an organelle, not a protein, DNA, RNA, Cell Type or Cell Line.",0.4615384615384615,"However | I-cell_type , | O the | O components | O of | O the | O NF-kappaB | B-protein complexes | I-protein were | O different | O in | O monocytes | B-cell_type and | O B | O cells | O , | O because | O p50 | B-protein is | O part | O of | O the | O NF-kappaB | O complex | O induced | O by | O CD40 | B-protein triggering | O in | O both | O monocytes | O and | O B | O cells | O , | O whereas | O p65 | B-protein was | O only | O induced | O in | O B | O cells | O . | O In | O contrast | O , | O although | O the | O Janus | B-protein kinase | I-protein 3 | I-protein tyrosine | I-protein kinase | I-protein was | O associated | O with | O CD40 | B-protein molecules | I-protein in | O both | O monocytes | O and | O resting | O B | O cells | O , | O Janus | O kinase | O 3 | O phosphorylation | O induction | O was | O observed | O only | O in | O CD40-activated | O monocytes | O , | O with | O subsequent | O induction | O of | O STAT5a | B-protein DNA | I-protein binding | I-protein activity | I-protein in | O the | O nucleus | O . | B-cell_type","However | O , | O the | O components | O of | O the | O NF-kappaB | B-protein complexes | I-protein were | O different | O in | O monocytes | B-cell_type and | O B | O cells | O , | O because | O p50 | B-protein is | O part | O of | O the | O NF-kappaB | B-protein complex | I-protein induced | O by | O CD40 | B-protein triggering | O in | O both | O monocytes | B-cell_type and | O B | B-cell_type cells | I-cell_type , | O whereas | O p65 | B-protein was | O only | O induced | O in | O B | B-cell_type cells | I-cell_type . | O In | O contrast | O , | O although | O the | O Janus | B-protein kinase | I-protein 3 | I-protein tyrosine | I-protein kinase | I-protein was | O associated | O with | O CD40 | B-protein molecules | O in | O both | O monocytes | B-cell_type and | O resting | B-cell_type B | I-cell_type cells | I-cell_type , | O Janus | B-protein kinase | I-protein 3 | I-protein phosphorylation | O induction | O was | O observed | O only | O in | O CD40-activated | B-cell_line monocytes | I-cell_line , | O with | O subsequent | O induction | O of | O STAT5a | B-protein DNA | O binding | O activity | O in | O the | O nucleus | O . | O",False
"In a previous study , we demonstrated that bufalin , which is an active principle of Chinese medicine , chan'su , caused apoptosis in human leukemia U937 cells by anomalous activation of mitogen-activated protein kinase ( MAPK ) via the signaling pathway of Ras , Raf-1 , and MAPK kinase-1 .","['human leukemia U937 cells', 'mitogen-activated protein kinase', 'MAPK', 'Ras', 'Raf-1', 'MAPK kinase-1']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_line', 'I-cell_line', 'I-cell_line', 'I-cell_line', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'B-protein', 'O', 'O', 'B-protein', 'I-protein', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_line', 'I-cell_line', 'I-cell_line', 'I-cell_line', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'I-protein', 'O', 'B-protein', 'O', 'O', 'B-protein', 'I-protein', 'O']","1. bufalin | True | as it is a protein (protein)
2. Chinese medicine | False | as it is a discipline and not a specific protein, DNA, RNA, Cell Type or Cell Line
3. chan'su | False | as it identifies a source of the bufalin protein, but not an entity in this context
4. apoptosis | False | as it is a process
5. human leukemia U937 cells | True | as they are a specific cell line (cell_line)
6. mitogen-activated protein kinase ( MAPK ) | True | as it is a protein (protein)
7. signaling pathway of Ras | True | as Ras is a family of related proteins (protein)
8. Raf-1 | True | as it is a protein (protein)
9. MAPK kinase-1 | True | as it is a protein (protein)",0.6666666666666666,"In | O a | O previous | O study | O , | O we | O demonstrated | O that | O bufalin | B-protein , | O which | O is | O an | O active | O principle | O of | O Chinese | O medicine | O , | O chan'su | O , | O caused | O apoptosis | O in | O human | B-cell_line leukemia | I-cell_line U937 | I-cell_line cells | I-cell_line by | O anomalous | O activation | O of | O mitogen-activated | B-protein protein | I-protein kinase | I-protein ( | O MAPK | O ) | O via | O the | O signaling | B-protein pathway | I-protein of | I-protein Ras | I-protein , | O Raf-1 | B-protein , | O and | O MAPK | B-protein kinase-1 | I-protein . | O","In | O a | O previous | O study | O , | O we | O demonstrated | O that | O bufalin | O , | O which | O is | O an | O active | O principle | O of | O Chinese | O medicine | O , | O chan'su | O , | O caused | O apoptosis | O in | O human | B-cell_line leukemia | I-cell_line U937 | I-cell_line cells | I-cell_line by | O anomalous | O activation | O of | O mitogen-activated | B-protein protein | I-protein kinase | I-protein ( | O MAPK | B-protein ) | O via | O the | O signaling | O pathway | O of | O Ras | B-protein , | O Raf-1 | B-protein , | O and | O MAPK | B-protein kinase-1 | I-protein . | O",False
"Three mutants ( -201/-184 NXS , -165/-148 NXS , and -147/-130 NXS ) had effects on viral replication that were much more severe than the effects predicted from their performance in transfection analyses , and the effects of two LS mutations ( -201/-184 NXS and -183/-166 NXS ) were not predicted by their effects in transfection .",[],"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'B-protein/DNA/RNA', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","1. Mutants (-201/-184 NXS, -165/-148 NXS, and -147/-130 NXS) | True | as they represent modified versions of a protein, DNA, or RNA (protein/DNA/RNA).
2. Viral Replication | False | as it represents a biological process, not a protein, DNA, RNA, Cell Type, or Cell Line.
3. LS mutations (-201/-184 NXS and -183/-166 NXS) | True | as mutations refer to changes in the DNA sequence (DNA).
4. Transfection | False | as it refers to a method or process, not a protein, DNA, RNA, Cell Type or Cell Line.",0.0,"Three | O mutants | B-protein/DNA/RNA ( | O -201/-184 | O NXS | O , | O -165/-148 | O NXS | O , | O and | O -147/-130 | O NXS | O ) | O had | O effects | O on | O viral | O replication | O that | O were | O much | O more | O severe | O than | O the | O effects | O predicted | O from | O their | O performance | O in | O transfection | O analyses | O , | O and | O the | O effects | O of | O two | O LS | B-DNA mutations | I-DNA ( | O -201/-184 | O NXS | O and | O -183/-166 | O NXS | O ) | O were | O not | O predicted | O by | O their | O effects | O in | O transfection | O . | O","Three | O mutants | O ( | O -201/-184 | O NXS | O , | O -165/-148 | O NXS | O , | O and | O -147/-130 | O NXS | O ) | O had | O effects | O on | O viral | O replication | O that | O were | O much | O more | O severe | O than | O the | O effects | O predicted | O from | O their | O performance | O in | O transfection | O analyses | O , | O and | O the | O effects | O of | O two | O LS | O mutations | O ( | O -201/-184 | O NXS | O and | O -183/-166 | O NXS | O ) | O were | O not | O predicted | O by | O their | O effects | O in | O transfection | O . | O",False
"Proinflammatory neutrophil stimuli also promoted the accumulation of IkappaB-alpha mRNA transcripts , resulting in the reexpression of the IkappaB-alpha protein .","['Proinflammatory neutrophil', 'IkappaB-alpha mRNA transcripts', 'IkappaB-alpha protein']","['B-cell_type', 'I-cell_type', 'O', 'O', 'O', 'O', 'O', 'O', 'B-RNA', 'I-RNA', 'I-RNA', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-RNA', 'I-RNA', 'I-RNA', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O']","1. Proinflammatory neutrophil stimuli | False | as it is a process
2. IkappaB-alpha mRNA transcripts | True | as it is a type of RNA (RNA)
3. IkappaB-alpha protein | True | as it is a type of protein (protein)",0.8,"Proinflammatory | O neutrophil | O stimuli | O also | O promoted | O the | O accumulation | O of | O IkappaB-alpha | B-RNA mRNA | I-RNA transcripts | I-RNA , | O resulting | O in | O the | O reexpression | O of | O the | O IkappaB-alpha | B-protein protein | I-protein . | O","Proinflammatory | B-cell_type neutrophil | I-cell_type stimuli | O also | O promoted | O the | O accumulation | O of | O IkappaB-alpha | B-RNA mRNA | I-RNA transcripts | I-RNA , | O resulting | O in | O the | O reexpression | O of | O the | O IkappaB-alpha | B-protein protein | I-protein . | O",False
These data provide the evidence that activation of human peripheral blood T cells through the AIM activation pathway regulate the activity of AP-1 .,"['human peripheral blood T cells', 'AP-1']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'I-cell_type', 'I-cell_type', 'I-cell_type', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'I-cell_type', 'I-cell_type', 'I-cell_type', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'O', 'O', 'O', 'O', 'B-protein', 'O']","1. data | False | as it is an abstract concept
        2. human peripheral blood T cells | True | as they are specified cell type (cell_type)
        3. AIM activation pathway | True | as it is a protein (protein)
        4. AP-1 (Activator Protein 1) | True | as it is a protein (protein)
        5. activity | False | as it is a process
        6. evidence | False | as it is an abstract concept
        7. Activation | False | as it is a process
",0.8,These | O data | O provide | O the | O evidence | O that | O activation | O of | O human | B-cell_type peripheral | I-cell_type blood | I-cell_type T | I-cell_type cells | I-cell_type through | O the | O AIM | B-protein activation | I-protein pathway | I-protein regulate | O the | O activity | O of | O AP-1 | B-protein . | O,These | O data | O provide | O the | O evidence | O that | O activation | O of | O human | B-cell_type peripheral | I-cell_type blood | I-cell_type T | I-cell_type cells | I-cell_type through | O the | O AIM | O activation | O pathway | O regulate | O the | O activity | O of | O AP-1 | B-protein . | O,False
The cascade of events within the first few minutes of T cell stimulation has been well characterized .,['T cell'],"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'O', 'O', 'O', 'O', 'O', 'O']","1. cascade of events | False | as it is a process 
2. T cell stimulation | False | as it is not a protein, DNA, RNA, Cell Type or Cell Line but rather a process.
3. T cell | True | as T cells are a type of cell (cell_type)",1.0,The | O cascade | O of | O events | O within | O the | O first | O few | O minutes | O of | O T | B-cell_type cell | I-cell_type stimulation | O has | O been | O well | O characterized | O . | O,The | O cascade | O of | O events | O within | O the | O first | O few | O minutes | O of | O T | B-cell_type cell | I-cell_type stimulation | O has | O been | O well | O characterized | O . | O,True
A novel HIV-1 isolate containing alterations affecting the NF-kappa B element .,['NF-kappa B element'],"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'I-DNA', 'O']","['O', 'O', 'B-cell_line', 'I-cell_line', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'O']","1. HIV-1 isolate | True | as it is a kind of cell line (cell_line)
2. alterations | False | as it is a process
3. NF-kappa B element | True | as it is the protein protein-NF-kappa B, in its function as a DNA-binding element (protein).",0.0,A | O novel | O HIV-1 | B-cell_line isolate | I-cell_line containing | O alterations | O affecting | O the | O NF-kappa | B-protein B | I-protein element | I-protein . | O,A | O novel | O HIV-1 | O isolate | O containing | O alterations | O affecting | O the | O NF-kappa | B-DNA B | I-DNA element | I-DNA . | O,False
"Upon TPA treatment , the activity of ERK1 and ERK2 rapidly increased , with maximal induction between 1 and 3 h , while ERK2 protein levels remained constant .","['ERK1', 'ERK2', 'ERK2']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","1. TPA treatment | False | as it is a process or procedure, not a protein, DNA, RNA, Cell Type, or Cell Line
2. activity of ERK1 and ERK2 | False | as it is about the functioning or action of certain proteins, not the proteins themselves
3. ERK1 | True | as it is a protein (protein)
4. ERK2 | True | as it is a protein (protein)
5. ERK2 protein levels | False | as it represents a quantity or measurement, not a protein, DNA, RNA, Cell Type, or Cell Line.",0.8,"Upon | O TPA | O treatment | O , | O the | O activity | O of | O ERK1 | B-protein and | O ERK2 | B-protein rapidly | O increased | O , | O with | O maximal | O induction | O between | O 1 | O and | O 3 | O h | O , | O while | O ERK2 | O protein | O levels | O remained | O constant | O . | O","Upon | O TPA | O treatment | O , | O the | O activity | O of | O ERK1 | B-protein and | O ERK2 | B-protein rapidly | O increased | O , | O with | O maximal | O induction | O between | O 1 | O and | O 3 | O h | O , | O while | O ERK2 | B-protein protein | O levels | O remained | O constant | O . | O",False
Two of these motifs are part of a highly conserved and inducible dyad symmetry element shown previously to control a remote IL-2 enhancer and the CD18 promoter .,"['dyad symmetry element', 'IL-2 enhancer', 'CD18 promoter']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'I-DNA', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'O', 'O', 'B-DNA', 'I-DNA', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'I-DNA', 'I-DNA', 'I-DNA', 'I-DNA', 'I-DNA', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'O', 'O', 'B-DNA', 'I-DNA', 'O']","1. motifs | False | as they refer generally to a common theme or pattern (in this case in DNA or RNA sequence), but are not specifically protein, DNA, RNA, cell type, or cell line 
2. highly conserved and inducible dyad symmetry element | True | as it refers to a specific structure within DNA (DNA)
3. IL-2 enhancer | True | as it refers to a region of DNA that can bind proteins to enhance transcription level of a gene (DNA)
4. CD18 promoter | True | as it refers to a region of DNA that initiates transcription of a particular gene (DNA)",0.6666666666666666,Two | O of | O these | O motifs | O are | O part | O of | O a | O highly | B-DNA conserved | I-DNA and | I-DNA inducible | I-DNA dyad | I-DNA symmetry | I-DNA element | I-DNA shown | O previously | O to | O control | O a | O remote | O IL-2 | B-DNA enhancer | I-DNA and | O the | O CD18 | B-DNA promoter | I-DNA . | O,Two | O of | O these | O motifs | O are | O part | O of | O a | O highly | O conserved | O and | O inducible | O dyad | B-DNA symmetry | I-DNA element | I-DNA shown | O previously | O to | O control | O a | O remote | O IL-2 | B-DNA enhancer | I-DNA and | O the | O CD18 | B-DNA promoter | I-DNA . | O,False
"MATERIAL AND METHODS : In the present study , we analyzed the effects of CyA , aspirin , and indomethacin on T cell proliferation using a proliferation assay .",[],"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'O', 'O', 'O', 'O', 'O', 'O']","1. CyA | True | it is short form for Cyclosporin A which is a drug that interacts with proteins (protein)
2. Aspirin | False | it is a drug, not a protein, DNA, RNA, Cell Type or Cell Line
3. Indomethacin | False | it is a drug, not a protein, DNA, RNA, Cell Type or Cell Line
4. T cell | True | they are a type of cell (cell_type)
5. Proliferation assay | False | it is a process or a method, not a protein, DNA, RNA, Cell Type or Cell Line",0.0,"MATERIAL | O AND | O METHODS | O : | O In | O the | O present | O study | O , | O we | O analyzed | O the | O effects | O of | O CyA | B-protein , | O aspirin | O , | O and | O indomethacin | O on | O T | B-cell_type cell | I-cell_type proliferation | O using | O a | O proliferation | O assay | O . | O","MATERIAL | O AND | O METHODS | O : | O In | O the | O present | O study | O , | O we | O analyzed | O the | O effects | O of | O CyA | O , | O aspirin | O , | O and | O indomethacin | O on | O T | O cell | O proliferation | O using | O a | O proliferation | O assay | O . | O",False
"In addition , our data suggests that the rapid PMA-mediated induction of collagenase-1 transcription is controlled by a mechanism distinct from that regulating the sustained expression of this proteinase in activated macrophages .","['collagenase-1', 'proteinase', 'activated macrophages']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'B-cell_type', 'I-cell_type', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'B-cell_type', 'I-cell_type', 'O']","1. PMA | True | Phorbol 12-myristate 13-acetate (PMA) is often used in research as a protein kinase C (PKC) activator. Although it's often used as a tool in research, it isn't exactly a protein or cell type itself, so this can be debated if this entity should be included in the list.
2. collagenase-1 | True | it is a protein (protein).
3. transcription | False | as it is a process, not a protein, DNA, RNA, Cell Type or Cell Line.
4. proteinase | True | it is a type of protein (protein).
5. activated macrophages | True | they are a type of cell (cell_type).",1.0,"In | O addition | O , | O our | O data | O suggests | O that | O the | O rapid | O PMA-mediated | O induction | O of | O collagenase-1 | B-protein transcription | O is | O controlled | O by | O a | O mechanism | O distinct | O from | O that | O regulating | O the | O sustained | O expression | O of | O this | O proteinase | B-protein in | O activated | B-cell_type macrophages | I-cell_type . | O","In | O addition | O , | O our | O data | O suggests | O that | O the | O rapid | O PMA-mediated | O induction | O of | O collagenase-1 | B-protein transcription | O is | O controlled | O by | O a | O mechanism | O distinct | O from | O that | O regulating | O the | O sustained | O expression | O of | O this | O proteinase | B-protein in | O activated | B-cell_type macrophages | I-cell_type . | O",True
"Both antioxidants inhibited TNF -or PMA-induced NF-kappa B activity in U1 cells , as well as the sustained NF-kappa B activity permanently induced by the virus itself in chronically HIV-infected U937 cells .","['TNF', 'NF-kappa B', 'U1 cells', 'NF-kappa B', 'U937 cells']","['O', 'O', 'O', 'B-protein', 'O', 'O', 'B-protein', 'I-protein', 'O', 'O', 'B-cell_line', 'I-cell_line', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_line', 'I-cell_line', 'O']","['I-protein', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_line', 'I-cell_line', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_line', 'I-cell_line', 'B-protein']","1. antioxidants | False | as they are a substance, not a protein, DNA, RNA, Cell Type or Cell Line
2. TNF | True | as it is Tumor necrosis factor, a type of protein (protein)
3. PMA | False | Phorbol myristate acetate (PMA) is a substance used to stimulate cells, not a protein, DNA, RNA, Cell Type or Cell Line
4. NF-kappa B | True | given it is a frequently activated protein (protein)
5. U1 cells | True | as it is a cell line (cell_line)
6. virus | False | as it is not a protein, DNA, RNA, Cell Type or Cell Line
7. HIV | False | as it is a virus, not a protein, DNA, RNA, Cell Type or Cell Line
8. U937 cells | True | as they are a cell line (cell_line).",0.6,"Both | I-protein antioxidants | O inhibited | O TNF | B-protein -or | O PMA-induced | O NF-kappa | O B | O activity | O in | O U1 | B-cell_line cells | I-cell_line , | O as | O well | O as | O the | O sustained | O NF-kappa | O B | O activity | O permanently | O induced | O by | O the | O virus | O itself | O in | O chronically | O HIV-infected | O U937 | B-cell_line cells | I-cell_line . | B-protein","Both | O antioxidants | O inhibited | O TNF | B-protein -or | O PMA-induced | O NF-kappa | B-protein B | I-protein activity | O in | O U1 | B-cell_line cells | I-cell_line , | O as | O well | O as | O the | O sustained | O NF-kappa | B-protein B | I-protein activity | O permanently | O induced | O by | O the | O virus | O itself | O in | O chronically | O HIV-infected | O U937 | B-cell_line cells | I-cell_line . | O",False
"The preferential induction of c-jun by H2O2 did not represent redox stabilization of mRNA transcripts , and oxidative signals closely resembled PHA/PMA stimulation by effectively transactivating the full length c-jun promoter via the proximal jun1 tumor promoter-responsive element ( TRE ) -like promoter element .","['c-jun', 'mRNA transcripts', 'c-jun', 'proximal jun1 tumor promoter-responsive element ( TRE ) -like promoter element']","['O', 'O', 'O', 'O', 'B-DNA', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-RNA', 'I-RNA', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DNA', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'I-DNA', 'I-DNA', 'I-DNA', 'I-DNA', 'I-DNA', 'I-DNA', 'I-DNA', 'I-DNA', 'I-DNA', 'O']","['O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-RNA', 'I-RNA', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'I-DNA', 'I-DNA', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","1. c-jun | True | as it is a protein (protein)
2. H2O2 | False | as it is not a protein, DNA, RNA, Cell Type or Cell Line
3. mRNA transcripts | True | as they are a type of RNA (RNA)
4. oxidative signals | False | as it is a process
5. PHA/PMA | True | as they are substances which stimulate protein reactions thus can be categorized as proteins (protein)
6. c-jun promoter | True | as it is a promoter region of DNA corresponding to the protein c-jun (DNA)
7. jun1 tumor promoter-responsive element ( TRE ) -like promoter element | True | as it is a specific DNA sequence (DNA).",0.2222222222222222,"The | O preferential | O induction | O of | O c-jun | B-protein by | O H2O2 | O did | O not | O represent | O redox | O stabilization | O of | O mRNA | B-RNA transcripts | I-RNA , | O and | O oxidative | O signals | O closely | O resembled | O PHA/PMA | B-protein stimulation | O by | O effectively | O transactivating | O the | O full | O length | O c-jun | B-DNA promoter | I-DNA via | O the | O proximal | O jun1 | B-DNA tumor | I-DNA promoter-responsive | I-DNA element | I-DNA ( | O TRE | O ) | O -like | O promoter | O element | O . | O","The | O preferential | O induction | O of | O c-jun | B-DNA by | O H2O2 | O did | O not | O represent | O redox | O stabilization | O of | O mRNA | B-RNA transcripts | I-RNA , | O and | O oxidative | O signals | O closely | O resembled | O PHA/PMA | O stimulation | O by | O effectively | O transactivating | O the | O full | O length | O c-jun | B-DNA promoter | O via | O the | O proximal | B-DNA jun1 | I-DNA tumor | I-DNA promoter-responsive | I-DNA element | I-DNA ( | I-DNA TRE | I-DNA ) | I-DNA -like | I-DNA promoter | I-DNA element | I-DNA . | O",False
Fibrinogen activates NF-kappa B transcription factors in mononuclear phagocytes .,"['Fibrinogen', 'NF-kappa B transcription factors', 'mononuclear phagocytes']","['B-protein', 'O', 'B-protein', 'I-protein', 'I-protein', 'I-protein', 'O', 'B-cell_type', 'I-cell_type', 'O']","['B-protein', 'O', 'B-protein', 'I-protein', 'I-protein', 'I-protein', 'O', 'B-cell_type', 'I-cell_type', 'O']","1. Fibrinogen | True | as it is a protein (protein) 
2. NF-kappa B transcription factors | True | as these are proteins that help regulate gene expression (protein)
3. mononuclear phagocytes | True | this is a type of cell (cell_type).",1.0,Fibrinogen | B-protein activates | O NF-kappa | B-protein B | I-protein transcription | I-protein factors | I-protein in | O mononuclear | B-cell_type phagocytes | I-cell_type . | O,Fibrinogen | B-protein activates | O NF-kappa | B-protein B | I-protein transcription | I-protein factors | I-protein in | O mononuclear | B-cell_type phagocytes | I-cell_type . | O,True
"Reciprocally , inhibition of NF-kappaB activation by a soluble peptide inhibitor or a dominant form of the NF-kappaB inhibitor , IkappaB , makes the cells more susceptible to Fas-mediated apoptosis .","['NF-kappaB', 'NF-kappaB', 'IkappaB']","['O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'I-protein', 'I-protein', 'I-protein', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","1. NF-kappaB | True | NF-kappaB is a protein (protein)
2. soluble peptide inhibitor | True | It can be categorized as a type of protein (protein)
3. dominant form of the NF-kappaB inhibitor | True | Referring likely to a version of protein (protein)
4. IkappaB | True | IkappaB is a protein (protein)
5. Cells | False | This is a general term and not a particular type of cell or cell line.
6. Fas-mediated apoptosis | False | This is a biological process and not an entity. ",0.5714285714285715,"Reciprocally | O , | O inhibition | O of | O NF-kappaB | B-protein activation | O by | O a | O soluble | B-protein peptide | I-protein inhibitor | I-protein or | O a | O dominant | B-protein form | I-protein of | I-protein the | I-protein NF-kappaB | I-protein inhibitor | I-protein , | O IkappaB | B-protein , | O makes | O the | O cells | O more | O susceptible | O to | O Fas-mediated | O apoptosis | O . | O","Reciprocally | O , | O inhibition | O of | O NF-kappaB | B-protein activation | O by | O a | O soluble | O peptide | O inhibitor | O or | O a | O dominant | O form | O of | O the | O NF-kappaB | B-protein inhibitor | O , | O IkappaB | B-protein , | O makes | O the | O cells | O more | O susceptible | O to | O Fas-mediated | O apoptosis | O . | O",False
NF-kappaB only partially mediates Epstein-Barr virus latent membrane protein 1 activation of B cells .,"['NF-kappaB', 'Epstein-Barr virus latent membrane protein 1']","['B-protein', 'O', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'I-protein', 'I-protein', 'I-protein', 'O', 'O', 'O', 'O', 'O']","['B-protein', 'O', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'I-protein', 'I-protein', 'I-protein', 'O', 'O', 'B-cell_type', 'I-cell_type', 'O']","1. NF-kappaB | True | as it is a protein (protein)
    2. Epstein-Barr virus latent membrane protein 1 | True | as it is a viral protein (protein)
    3. Activation | False | as it is a process
    4. B cells | True | as they are a type of cell (cell_type)",0.8,NF-kappaB | B-protein only | O partially | O mediates | O Epstein-Barr | B-protein virus | I-protein latent | I-protein membrane | I-protein protein | I-protein 1 | I-protein activation | O of | O B | B-cell_type cells | I-cell_type . | O,NF-kappaB | B-protein only | O partially | O mediates | O Epstein-Barr | B-protein virus | I-protein latent | I-protein membrane | I-protein protein | I-protein 1 | I-protein activation | O of | O B | O cells | O . | O,False
Ras-related GTP-binding proteins and leukocyte signal transduction .,"['Ras-related GTP-binding proteins', 'leukocyte']","['B-protein', 'I-protein', 'I-protein', 'O', 'B-cell_type', 'O', 'O', 'O']","['B-protein', 'I-protein', 'I-protein', 'O', 'O', 'O', 'O', 'O']","1. Ras-related GTP-binding proteins | True | as they are a group of proteins (protein)
2. leukocyte signal transduction | False | as it is a process and not a Protein, DNA, RNA, Cell Type or Cell Line.",0.6666666666666666,Ras-related | B-protein GTP-binding | I-protein proteins | I-protein and | O leukocyte | O signal | O transduction | O . | O,Ras-related | B-protein GTP-binding | I-protein proteins | I-protein and | O leukocyte | B-cell_type signal | O transduction | O . | O,False
"By comparison , an isotype-matched antibody had no effect on NF-kappa B activation .","['isotype-matched antibody', 'NF-kappa B']","['O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O', 'O']","['O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O', 'O', 'O', 'O', 'NF-κB', 'NF-κB', 'O', 'O']","1. isotype-matched antibody | True | as an antibody is a type of protein (protein)
   2. NF-kappa B | True | as Nuclear factor kappa B (NF-κB) is a protein (protein)
   3. activation | False | as ""activation"" is a process and not an entity.",0.5,"By | O comparison | O , | O an | O isotype-matched | B-protein antibody | I-protein had | O no | O effect | O on | O NF-kappa | NF-κB B | NF-κB activation | O . | O","By | O comparison | O , | O an | O isotype-matched | B-protein antibody | I-protein had | O no | O effect | O on | O NF-kappa | B-protein B | I-protein activation | O . | O",False
Xenogeneic human serum significantly ( P < 0.01 ) increased the number of adherent leukocytes as compared with porcine serum .,['adherent leukocytes'],"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'O', 'O', 'O', 'O', 'O', 'O']","1. Xenogeneic human serum | False | as it is a type of serum and does not qualify as a protein, DNA, RNA, Cell Type or Cell Line.
2. Adherent leukocytes | True | as they are a type of cell (cell_type)
3. Porcine serum | False | as it is a type of serum and does not qualify as a protein, DNA, RNA, Cell Type or Cell line.",1.0,Xenogeneic | O human | O serum | O significantly | O ( | O P | O < | O 0.01 | O ) | O increased | O the | O number | O of | O adherent | B-cell_type leukocytes | I-cell_type as | O compared | O with | O porcine | O serum | O . | O,Xenogeneic | O human | O serum | O significantly | O ( | O P | O < | O 0.01 | O ) | O increased | O the | O number | O of | O adherent | B-cell_type leukocytes | I-cell_type as | O compared | O with | O porcine | O serum | O . | O,True
OBJECTIVE : Many studies have suggested that there is a possible hormonal dysregulation of hypothalamic-pituitary-adrenal ( HPA ) axis and an increased cortisol clearance in patients with polycystic ovary syndrome ( PCOS ) .,[],"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","1. hormonal dysregulation | False | as it is a concept/process
2. hypothalamic-pituitary-adrenal ( HPA ) axis | False | while it refers to a system in the body, it is not a protein, DNA, RNA, Cell Type or Cell Line, thus it's not an entity.
3. cortisol | True | as it is a hormone, which is a kind of protein (protein).
4. patients with polycystic ovary syndrome ( PCOS ) | False | as it refers to a group of patients not a protein, DNA, RNA, Cell Type or Cell Line.",0.0,OBJECTIVE | O : | O Many | O studies | O have | O suggested | O that | O there | O is | O a | O possible | O hormonal | O dysregulation | O of | O hypothalamic-pituitary-adrenal | O ( | O HPA | O ) | O axis | O and | O an | O increased | O cortisol | B-protein clearance | O in | O patients | O with | O polycystic | O ovary | O syndrome | O ( | O PCOS | O ) | O . | O,OBJECTIVE | O : | O Many | O studies | O have | O suggested | O that | O there | O is | O a | O possible | O hormonal | O dysregulation | O of | O hypothalamic-pituitary-adrenal | O ( | O HPA | O ) | O axis | O and | O an | O increased | O cortisol | O clearance | O in | O patients | O with | O polycystic | O ovary | O syndrome | O ( | O PCOS | O ) | O . | O,False
"Altogether , the CD4 gene is regulated by several positive and negative regulatory mechanisms which come into play in a developmentally coordinated manner .",['CD4 gene'],"['O', 'O', 'O', 'B-DNA', 'I-DNA', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'B-DNA', 'I-DNA', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","1. CD4 gene | True | as it is a segment of DNA (DNA)
        2. regulatory mechanisms | False | as it is a process.
        3. developmentally coordinated manner | False | as it is a process.",1.0,"Altogether | O , | O the | O CD4 | B-DNA gene | I-DNA is | O regulated | O by | O several | O positive | O and | O negative | O regulatory | O mechanisms | O which | O come | O into | O play | O in | O a | O developmentally | O coordinated | O manner | O . | O","Altogether | O , | O the | O CD4 | B-DNA gene | I-DNA is | O regulated | O by | O several | O positive | O and | O negative | O regulatory | O mechanisms | O which | O come | O into | O play | O in | O a | O developmentally | O coordinated | O manner | O . | O",True
Recent isolation of the CD11b promoter shows that 92 base pairs ( bp ) of 5'-flanking DNA are sufficient to direct myeloid-specific expression of a reporter gene .,"['CD11b promoter', ""5'-flanking DNA"", 'reporter gene']","['O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'O']","['O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'O', 'O', 'B-DNA', 'I-DNA', 'I-DNA', 'O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O']","1. CD11b promoter | True | because it is a segment of DNA that initiates transcription of a particular gene (DNA)
2. 92 base pairs ( bp ) | True | because they are part of the DNA molecule (DNA)
3. 5'-flanking DNA | True | because it is a region of DNA adjacent to a gene (DNA)
4. myeloid-specific expression | False | because it represents a concept/process, not an entity
5. reporter gene | True | because it is a gene that researchers use to determine whether certain other genes have been taken up by or expressed in the cell or organism (protein)",0.5714285714285715,Recent | O isolation | O of | O the | O CD11b | B-DNA promoter | I-DNA shows | O that | O 92 | B-DNA base | I-DNA pairs | I-DNA ( | O bp | O ) | O of | O 5'-flanking | B-DNA DNA | I-DNA are | O sufficient | O to | O direct | O myeloid-specific | O expression | O of | O a | O reporter | B-protein gene | I-protein . | O,Recent | O isolation | O of | O the | O CD11b | B-DNA promoter | I-DNA shows | O that | O 92 | O base | O pairs | O ( | O bp | O ) | O of | O 5'-flanking | B-DNA DNA | I-DNA are | O sufficient | O to | O direct | O myeloid-specific | O expression | O of | O a | O reporter | B-DNA gene | I-DNA . | O,False
"To our knowledge , this represents the first demonstration that phagocytic stimuli can induce NF-kappa B activation in human neutrophils .","['NF-kappa B', 'human neutrophils']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O', 'O', 'B-cell_type', 'I-cell_type', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O', 'O', 'B-cell_type', 'I-cell_type', 'O']","1. phagocytic stimuli | False | as it's not a protein, DNA, RNA, Cell Type or Cell Line, it is a process
2. NF-kappa B | True | as it is a protein (protein)
3. human neutrophils | True | as they are a type of cell (cell_type)",1.0,"To | O our | O knowledge | O , | O this | O represents | O the | O first | O demonstration | O that | O phagocytic | O stimuli | O can | O induce | O NF-kappa | B-protein B | I-protein activation | O in | O human | B-cell_type neutrophils | I-cell_type . | O","To | O our | O knowledge | O , | O this | O represents | O the | O first | O demonstration | O that | O phagocytic | O stimuli | O can | O induce | O NF-kappa | B-protein B | I-protein activation | O in | O human | B-cell_type neutrophils | I-cell_type . | O",True
"This induction was not inhibited by treatment of the cells with a protein synthesis inhibitor , cycloheximide .",[],"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'O', 'B-protein', 'O']","1. Induction | False | as it is a process
2. Cells | True | but cannot be categorized under the specific types mentioned: protein (protein), group of proteins (protein), DNA, RNA, Cell Type (cell_type), Cell Line (cell_line)
3. Protein synthesis inhibitor | True | as it involves proteins inhibiting synthesis (protein)
4. Cycloheximide | True | as it is a known protein synthesis inhibitor (protein)",0.0,"This | O induction | O was | O not | O inhibited | O by | O treatment | O of | O the | O cells | B-protein with | O a | O protein | B-protein synthesis | I-protein inhibitor | I-protein , | O cycloheximide | B-protein . | O","This | O induction | O was | O not | O inhibited | O by | O treatment | O of | O the | O cells | O with | O a | O protein | O synthesis | O inhibitor | O , | O cycloheximide | O . | O",False
The studies described herein demonstrate that the activation domain .,[],"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","1. The studies | False | as they represent abstract concepts, not a protein, group of proteins, DNA, RNA, Cell Type or Cell Line.
2. Activation domain | True | as it refers to a part of a protein/DNA/RNA structure, hence can be considered as an entity.",0.0,The | O studies | O described | O herein | O demonstrate | O that | O the | O activation | O domain | O . | O,The | O studies | O described | O herein | O demonstrate | O that | O the | O activation | O domain | O . | O,True
Abnormalities for one or both probes were detected in 83/95 samples .,[],"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","1. Probes | False | The term ""probes"" can refer to many different kinds of substances or tools used in biology, but without specific context or nomenclature, we can't define it as a DNA, RNA, protein, cell line, or cell type.
2. 83/95 samples | False | Samples could include a variety of substances including DNA, cells, proteins, etc. However, without specific information, we cannot identify these as one of the entities.
3. Abnormalities | False | This term refers to a concept or condition and does not correspond to an entity such as DNA, RNA, proteins, cell type or cell line.",0.0,Abnormalities | O for | O one | O or | O both | O probes | O were | O detected | O in | O 83/95 | O samples | O . | O,Abnormalities | O for | O one | O or | O both | O probes | O were | O detected | O in | O 83/95 | O samples | O . | O,True
Pivotal role for the NFIL3/E4BP4 transcription factor in interleukin 3 -mediated survival of pro-B lymphocytes .,"['NFIL3/E4BP4 transcription factor', 'interleukin 3', 'pro-B lymphocytes']","['O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'O', 'B-protein', 'I-protein', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'O']","['O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'O', 'B-protein', 'I-protein', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'O']","1. NFIL3/E4BP4 transcription factor | True | as it is a protein (protein)
   2. Interleukin 3 (IL-3) | True | as it is a protein (protein)
   3. Survival | False | as it is a process 
   4. pro-B lymphocytes | True | as it is a type of cell (cell_type)",1.0,Pivotal | O role | O for | O the | O NFIL3/E4BP4 | B-protein transcription | I-protein factor | I-protein in | O interleukin | B-protein 3 | I-protein -mediated | O survival | O of | O pro-B | B-cell_type lymphocytes | I-cell_type . | O,Pivotal | O role | O for | O the | O NFIL3/E4BP4 | B-protein transcription | I-protein factor | I-protein in | O interleukin | B-protein 3 | I-protein -mediated | O survival | O of | O pro-B | B-cell_type lymphocytes | I-cell_type . | O,True
The effects of TNF-alpha on gene expression were examined by transient expression assays using reporter chloramphenicol acetyltransferase plasmids linked to regulatory elements from the HIV long terminal repeat ( LTR ) and the beta interferon promoter .,"['TNF-alpha', 'reporter chloramphenicol acetyltransferase plasmids', 'regulatory elements', 'HIV long terminal repeat', 'LTR', 'beta interferon promoter']","['O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'I-DNA', 'I-DNA', 'O', 'O', 'B-DNA', 'I-DNA', 'O', 'O', 'B-DNA', 'I-DNA', 'I-DNA', 'I-DNA', 'O', 'B-DNA', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'I-DNA', 'O']","['O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'I-DNA', 'I-DNA', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'I-DNA', 'I-DNA', 'O', 'O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'I-DNA', 'O']","1. TNF-alpha | True | as it is a protein (protein)
2. gene expression | False | as it is a process
3. reporter chloramphenicol acetyltransferase plasmids | True | as they are a type of DNA (DNA)
4. regulatory elements | False | as they are a process or function, not a concrete entity
5. HIV long terminal repeat ( LTR ) | True | as it is a sequence found in the DNA of HIV (DNA)
6. beta interferon promoter | True | It is a DNA sequence that helps start the process of copying a gene into RNA (DNA).",0.8,The | O effects | O of | O TNF-alpha | B-protein on | O gene | O expression | O were | O examined | O by | O transient | O expression | O assays | O using | O reporter | B-DNA chloramphenicol | I-DNA acetyltransferase | I-DNA plasmids | I-DNA linked | O to | O regulatory | O elements | O from | O the | O HIV | B-DNA long | I-DNA terminal | I-DNA repeat | I-DNA ( | O LTR | O ) | O and | O the | O beta | B-DNA interferon | I-DNA promoter | I-DNA . | O,The | O effects | O of | O TNF-alpha | B-protein on | O gene | O expression | O were | O examined | O by | O transient | O expression | O assays | O using | O reporter | B-DNA chloramphenicol | I-DNA acetyltransferase | I-DNA plasmids | I-DNA linked | O to | O regulatory | B-DNA elements | I-DNA from | O the | O HIV | B-DNA long | I-DNA terminal | I-DNA repeat | I-DNA ( | O LTR | B-DNA ) | O and | O the | O beta | B-DNA interferon | I-DNA promoter | I-DNA . | O,False
Study of Aldh1 gene expression during spleen development showed that the presence of Aldh1 mRNA inversely correlated with Hox11 .,"['Aldh1', 'Aldh1 mRNA', 'Hox11']","['O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-RNA', 'I-RNA', 'O', 'O', 'O', 'B-protein', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-RNA', 'I-RNA', 'O', 'O', 'O', 'B-protein', 'O']","1. Aldh1 gene | True | as it is a type of DNA
2. spleen development | False | as it is a biological process not a cell type, protein, DNA, RNA, or cell line. 
3. Aldh1 mRNA | True | as it is a molecule derived from the DNA (RNA)
4. Hox11 | True | as it is a protein (protein).",0.8,Study | O of | O Aldh1 | O gene | O expression | O during | O spleen | O development | O showed | O that | O the | O presence | O of | O Aldh1 | B-RNA mRNA | I-RNA inversely | O correlated | O with | O Hox11 | B-protein . | O,Study | O of | O Aldh1 | B-protein gene | O expression | O during | O spleen | O development | O showed | O that | O the | O presence | O of | O Aldh1 | B-RNA mRNA | I-RNA inversely | O correlated | O with | O Hox11 | B-protein . | O,False
We report here that monocytes/macrophages in human atherosclerotic lesions ( n = 12 ) express immunostainable PPARgamma .,"['monocytes/macrophages', 'immunostainable PPARgamma']","['O', 'O', 'O', 'O', 'B-cell_type', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O']","['O', 'O', 'O', 'O', 'B-cell_type', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O']","1. monocytes/macrophages | True | as they are a type of cell (cell_type)
2. human atherosclerotic lesions | False | as they are not a protein, DNA, RNA, Cell Type or Cell Line. This is a condition.
3. PPARgamma | True | as it is a protein (protein)",0.5,We | O report | O here | O that | O monocytes/macrophages | B-cell_type in | O human | O atherosclerotic | O lesions | O ( | O n | O = | O 12 | O ) | O express | O immunostainable | O PPARgamma | B-protein . | O,We | O report | O here | O that | O monocytes/macrophages | B-cell_type in | O human | O atherosclerotic | O lesions | O ( | O n | O = | O 12 | O ) | O express | O immunostainable | B-protein PPARgamma | I-protein . | O,False
"In contrast to MM cells , normal splenic B cells express dephosphorylated pRB .","['MM cells', 'splenic B cells', 'dephosphorylated pRB']","['O', 'O', 'O', 'B-cell_line', 'I-cell_line', 'O', 'O', 'B-cell_type', 'I-cell_type', 'I-cell_type', 'O', 'B-protein', 'I-protein', 'O']","['O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'O', 'B-cell_type', 'I-cell_type', 'I-cell_type', 'I-cell_type', 'O', 'B-protein', 'I-protein', 'O']","1. MM cells | True | as it's referring to a type of cancer cell (cell_type)
2. normal splenic B cells | True | as they are a type of cell (cell_type)
3. dephosphorylated pRB | True | as the term represents a modified form of pRB protein (protein)",0.3333333333333333,"In | O contrast | O to | O MM | B-cell_type cells | I-cell_type , | O normal | B-cell_type splenic | I-cell_type B | I-cell_type cells | I-cell_type express | O dephosphorylated | B-protein pRB | I-protein . | O","In | O contrast | O to | O MM | B-cell_line cells | I-cell_line , | O normal | O splenic | B-cell_type B | I-cell_type cells | I-cell_type express | O dephosphorylated | B-protein pRB | I-protein . | O",False
"As a first step toward elucidating the function of Cbl in TCR -initiated signaling , we evaluated the ability of wild-type Cbl or a transforming Cbl mutant ( 70Z/3 ) to induce transcriptional activation of a nuclear factor of activated T cells ( NFAT ) element derived from the interleukin 2 ( IL2 ) promoter in transiently cotransfected Jurkat-TAg T cells .","['Cbl', 'TCR', 'wild-type Cbl', 'Cbl mutant', 'nuclear factor of activated T cells ( NFAT ) element', 'interleukin 2 ( IL2 ) promoter', 'Jurkat-TAg T cells']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'I-DNA', 'I-DNA', 'I-DNA', 'I-DNA', 'I-DNA', 'I-DNA', 'I-DNA', 'I-DNA', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'I-DNA', 'I-DNA', 'I-DNA', 'I-DNA', 'O', 'O', 'O', 'B-cell_line', 'I-cell_line', 'I-cell_line', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'B-TCR', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'I-protein', 'I-protein', 'I-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_line', 'I-cell_line', 'I-cell_line', 'O']","1. Cbl | True | as it is a protein (protein)
2. TCR | True | T Cell Receptor (TCR) is a protein complex found on the surface of T cells (protein)
3. wild-type Cbl | True | The phrase refers to the normal, non-mutant version of the protein Cbl. (protein)
4. transforming Cbl mutant ( 70Z/3 ) | True | This is a genetically altered version of Cbl protein (protein)
5. nuclear factor of activated T cells ( NFAT ) | True | This is a protein important in immune response (protein)
6. interleukin 2 ( IL2 ) promoter | True | This is a segment of DNA which regulates the expression of the Interleukin-2 gene (DNA)
7. Jurkat-TAg T cells | True | They are a specific cell line used in research (cell_line) 
8. transcriptional activation | False | This term refers to a process, not a biological entity.
9. signaling | False | This is a biological process, not a protein or cell type.",0.4285714285714285,"As | O a | O first | O step | O toward | O elucidating | O the | O function | O of | O Cbl | B-protein in | O TCR | B-TCR -initiated | O signaling | O , | O we | O evaluated | O the | O ability | O of | O wild-type | B-protein Cbl | I-protein or | O a | O transforming | B-protein Cbl | I-protein mutant | I-protein ( | O 70Z/3 | O ) | O to | O induce | O transcriptional | O activation | O of | O a | O nuclear | B-protein factor | I-protein of | I-protein activated | I-protein T | I-protein cells | I-protein ( | O NFAT | O ) | O element | O derived | O from | O the | O interleukin | B-DNA 2 | I-DNA ( | O IL2 | O ) | O promoter | O in | O transiently | O cotransfected | O Jurkat-TAg | B-cell_line T | I-cell_line cells | I-cell_line . | O","As | O a | O first | O step | O toward | O elucidating | O the | O function | O of | O Cbl | B-protein in | O TCR | B-protein -initiated | O signaling | O , | O we | O evaluated | O the | O ability | O of | O wild-type | B-protein Cbl | I-protein or | O a | O transforming | O Cbl | B-protein mutant | I-protein ( | O 70Z/3 | O ) | O to | O induce | O transcriptional | O activation | O of | O a | O nuclear | B-DNA factor | I-DNA of | I-DNA activated | I-DNA T | I-DNA cells | I-DNA ( | I-DNA NFAT | I-DNA ) | I-DNA element | I-DNA derived | O from | O the | O interleukin | B-DNA 2 | I-DNA ( | I-DNA IL2 | I-DNA ) | I-DNA promoter | I-DNA in | O transiently | O cotransfected | O Jurkat-TAg | B-cell_line T | I-cell_line cells | I-cell_line . | O",False
"Functional studies in extra-renal , nonepithelial cells such as smooth muscle cells and more recently circulating human lymphocytes have provided increasing evidence that aldosterone produces not only classical genomic effects , but also rapid non-genomic effects on transmembrane electrolyte movements .","['extra-renal , nonepithelial cells', 'smooth muscle cells', 'human lymphocytes']","['O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'I-cell_type', 'I-cell_type', 'O', 'O', 'B-cell_type', 'I-cell_type', 'I-cell_type', 'O', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'I-cell_type', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'I-cell_type', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","1. extra-renal | False | as it is an adjective and adjectives are not entities.
2. nonepithelial cells | False | as it is a broad category and vague cell description which does not specify a particular cell type.
3. smooth muscle cells | True | as they are a specific type of cell (cell_type).
4. circulating human lymphocytes | True | as they are a specific type of cell (cell_type).
5. aldosterone | True | as it is a protein (protein).
6. genomic effects | False | as it is a process or effect, not an entity.
7. non-genomic effects | False | as it is a process or effect, not an entity.
8. transmembrane electrolyte movements | False | as it is process or event, not an entity.",0.3333333333333333,"Functional | O studies | O in | O extra-renal | O , | O nonepithelial | O cells | O such | O as | O smooth | B-cell_type muscle | I-cell_type cells | I-cell_type and | O more | O recently | O circulating | B-cell_type human | I-cell_type lymphocytes | I-cell_type have | O provided | O increasing | O evidence | O that | O aldosterone | B-protein produces | O not | O only | O classical | O genomic | O effects | O , | O but | O also | O rapid | O non-genomic | O effects | O on | O transmembrane | O electrolyte | O movements | O . | O","Functional | O studies | O in | O extra-renal | B-cell_type , | I-cell_type nonepithelial | I-cell_type cells | I-cell_type such | O as | O smooth | B-cell_type muscle | I-cell_type cells | I-cell_type and | O more | O recently | O circulating | O human | B-cell_type lymphocytes | I-cell_type have | O provided | O increasing | O evidence | O that | O aldosterone | O produces | O not | O only | O classical | O genomic | O effects | O , | O but | O also | O rapid | O non-genomic | O effects | O on | O transmembrane | O electrolyte | O movements | O . | O",False
Cell-to-cell contact activates the long terminal repeat of human immunodeficiency virus 1 through its kappaB motif .,"['long terminal repeat', 'kappaB motif']","['O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'I-DNA', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'O']","['O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'I-DNA', 'I-DNA', 'I-DNA', 'I-DNA', 'I-DNA', 'I-DNA', 'O', 'O', 'B-DNA', 'I-DNA', 'O']","1. long terminal repeat of human immunodeficiency virus 1 | True | as this represents part of the virus's genetic structure - specifically a DNA segment (DNA)
2. kappaB motif | True | it is a segment of DNA that can bind certain proteins (DNA).",0.5,Cell-to-cell | O contact | O activates | O the | O long | B-DNA terminal | I-DNA repeat | I-DNA of | I-DNA human | I-DNA immunodeficiency | I-DNA virus | I-DNA 1 | I-DNA through | O its | O kappaB | B-DNA motif | I-DNA . | O,Cell-to-cell | O contact | O activates | O the | O long | B-DNA terminal | I-DNA repeat | I-DNA of | O human | O immunodeficiency | O virus | O 1 | O through | O its | O kappaB | B-DNA motif | I-DNA . | O,False
These cells were examined for ER mRNA by reverse transcription nested polymerase chain reaction .,['ER mRNA'],"['O', 'O', 'O', 'O', 'O', 'B-RNA', 'I-RNA', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B-cell_type', 'I-cell_type', 'O', 'O', 'O', 'B-messenger RNA', 'I-messenger RNA', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","1. These cells | True | This term ambiguously refers to some type of cells, but without context we can't determine the exact cell type (cell_type)
2. ER mRNA | True | This refers to the mRNA (messenger RNA) for the ER (Endoplasmic Reticulum) protein (RNA)
3. reverse transcription nested polymerase chain reaction | False | This is a procedure or method, not an entity.",0.0,These | B-cell_type cells | I-cell_type were | O examined | O for | O ER | B-messenger RNA mRNA | I-messenger RNA by | O reverse | O transcription | O nested | O polymerase | O chain | O reaction | O . | O,These | O cells | O were | O examined | O for | O ER | B-RNA mRNA | I-RNA by | O reverse | O transcription | O nested | O polymerase | O chain | O reaction | O . | O,False
Significant differences were observed from day 4 onward .,[],"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","1. Day 4 | False | as it is a time reference, not a protein, DNA, RNA, Cell Type or Cell Line.
2. Significant differences | False | As it's an observed effect, not a protein, DNA, RNA, Cell Type, or Cell Line.",0.0,Significant | O differences | O were | O observed | O from | O day | O 4 | O onward | O . | O,Significant | O differences | O were | O observed | O from | O day | O 4 | O onward | O . | O,True
"We questioned whether or not IL-10 and IL-4 affected the expression of transcription factors that are known to be involved in the control of the IL-6 transcription rate , namely activator protein-1 ( AP-1 ) , nuclear factor IL-6 ( NF-IL6 ) , and nuclear factor kappa B ( NF-kappaB ) .","['IL-10', 'IL-4', 'transcription factors', 'IL-6', 'AP-1', 'nuclear factor', 'IL-6', 'NF-IL6', 'nuclear factor kappa B', 'NF-kappaB']","['O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'B-protein', 'I-protein', 'B-protein', 'O', 'B-protein', 'O', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'I-protein', 'O', 'B-protein', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'I-protein', 'O', 'O', 'O', 'O']","1. IL-10 | True | it is a protein (protein)
2. IL-4 | True | it is also a protein (protein)
3. expression | False | as it is a concept
4. transcription factors | True | These are proteins (protein)  
5. IL-6 | True | it is a protein (protein)
6. activator protein-1 ( AP-1 ) | True | it is a protein (protein)
7. nuclear factor IL-6 ( NF-IL6 ) | True | it is a protein (protein)
8. nuclear factor kappa B ( NF-kappaB ) | True | it is a protein (protein)",0.588235294117647,"We | O questioned | O whether | O or | O not | O IL-10 | B-protein and | O IL-4 | B-protein affected | O the | O expression | O of | O transcription | B-protein factors | I-protein that | O are | O known | O to | O be | O involved | O in | O the | O control | O of | O the | O IL-6 | B-protein transcription | O rate | O , | O namely | O activator | B-protein protein-1 | I-protein ( | O AP-1 | O ) | O , | O nuclear | B-protein factor | I-protein IL-6 | I-protein ( | O NF-IL6 | O ) | O , | O and | O nuclear | B-protein factor | I-protein kappa | I-protein B | I-protein ( | O NF-kappaB | O ) | O . | O","We | O questioned | O whether | O or | O not | O IL-10 | B-protein and | O IL-4 | B-protein affected | O the | O expression | O of | O transcription | B-protein factors | I-protein that | O are | O known | O to | O be | O involved | O in | O the | O control | O of | O the | O IL-6 | B-protein transcription | O rate | O , | O namely | O activator | O protein-1 | O ( | O AP-1 | B-protein ) | O , | O nuclear | B-protein factor | I-protein IL-6 | B-protein ( | O NF-IL6 | B-protein ) | O , | O and | O nuclear | B-protein factor | I-protein kappa | I-protein B | I-protein ( | O NF-kappaB | B-protein ) | O . | O",False
"The intracellular events that lead to the inactivation of I kappa B , i.e. the activation of NF-kappa B , are complex .","['I kappa B', 'NF-kappa B']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O', 'O', 'O', 'O']","1. intracellular events | False | these are processes
2. I kappa B | True | because it's a protein (protein)
3. activation | False | because it's a process
4. NF-kappa B | True | because it's a protein (protein)
5. complex | False | this is an adjective in this context.",1.0,"The | O intracellular | O events | O that | O lead | O to | O the | O inactivation | O of | O I | B-protein kappa | I-protein B | I-protein , | O i.e. | O the | O activation | O of | O NF-kappa | B-protein B | I-protein , | O are | O complex | O . | O","The | O intracellular | O events | O that | O lead | O to | O the | O inactivation | O of | O I | B-protein kappa | I-protein B | I-protein , | O i.e. | O the | O activation | O of | O NF-kappa | B-protein B | I-protein , | O are | O complex | O . | O",True
"Even so , medullary thymocytes remain at least partially susceptible to negative selection even as they continue to mature .",['medullary thymocytes'],"['O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","1. medullary thymocytes | True | as they are a type of cell (cell_type)
2. negative selection | False | as it is a process
3. mature | False | as it is a process",1.0,"Even | O so | O , | O medullary | B-cell_type thymocytes | I-cell_type remain | O at | O least | O partially | O susceptible | O to | O negative | O selection | O even | O as | O they | O continue | O to | O mature | O . | O","Even | O so | O , | O medullary | B-cell_type thymocytes | I-cell_type remain | O at | O least | O partially | O susceptible | O to | O negative | O selection | O even | O as | O they | O continue | O to | O mature | O . | O",True
"As compared with other open-reading frames embedded into HIV/SIV genome , this degree of stability is unprecedented .","['open-reading frames', 'HIV/SIV genome']","['O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'O', 'O', 'B-DNA', 'I-DNA', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'O', 'O', 'B-RNA', 'I-RNA', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","1. open-reading frames | True | This refers to a sequence of DNA (DNA)
2. HIV/SIV genome | True | This refers to the genome of the HIV and SIV viruses, which is composed of RNA (RNA)
3. degree of stability | False | This refers to an abstract concept, not a protein, DNA, RNA, Cell Type or Cell Line.",0.5,"As | O compared | O with | O other | O open-reading | B-DNA frames | I-DNA embedded | O into | O HIV/SIV | B-RNA genome | I-RNA , | O this | O degree | O of | O stability | O is | O unprecedented | O . | O","As | O compared | O with | O other | O open-reading | B-DNA frames | I-DNA embedded | O into | O HIV/SIV | B-DNA genome | I-DNA , | O this | O degree | O of | O stability | O is | O unprecedented | O . | O",False
The induction of this promoter was confirmed in COS7 cells .,['COS7 cells'],"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_line', 'I-cell_line', 'O']","['O', 'O', 'O', 'O', 'B-DNA', 'O', 'O', 'O', 'B-cell_line', 'I-cell_line', 'O']","1. Promoter | True | as it is a region of DNA (DNA)
2. COS7 cells | True | as it is a cell line type (cell_line)
3. The induction | False | as it is a process.",0.6666666666666666,The | O induction | O of | O this | O promoter | B-DNA was | O confirmed | O in | O COS7 | B-cell_line cells | I-cell_line . | O,The | O induction | O of | O this | O promoter | O was | O confirmed | O in | O COS7 | B-cell_line cells | I-cell_line . | O,False
The Epstein-Barr virus protein EBNA2 acts as a transcriptional activator of cellular and viral genes and plays a crucial role in the immortalization of human primary B-cells by EBV .,"['Epstein-Barr virus protein EBNA2', 'transcriptional activator', 'cellular and viral genes', 'human primary B-cells']","['O', 'B-protein', 'I-protein', 'I-protein', 'I-protein', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O', 'B-DNA', 'I-DNA', 'I-DNA', 'I-DNA', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'I-cell_type', 'O', 'O', 'O']","['O', 'B-protein', 'I-protein', 'I-protein', 'I-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'I-cell_type', 'O', 'O', 'O']","1. Epstein-Barr virus protein EBNA2 | True | as it is a expressed protein of Epstein-Barr virus (protein)
2. Transcriptional activator | False | as it is a functional classification of certain proteins, but not a specific protein
3. Cellular genes | True | cellular genes are DNA sequences 
4. Viral genes | True | viral genes are DNA or RNA sequences 
5. Immortalization | False | as it is a process
6. Human primary B-cells | True | as they are a specific type of white blood cells (cell_type)
7. EBV | True | as it is a known abbreviation of Epstein-Barr virus, a type of virus which can be an entity.",0.6666666666666666,The | O Epstein-Barr | B-protein virus | I-protein protein | I-protein EBNA2 | I-protein acts | O as | O a | O transcriptional | O activator | O of | O cellular | O and | O viral | O genes | O and | O plays | O a | O crucial | O role | O in | O the | O immortalization | O of | O human | B-cell_type primary | I-cell_type B-cells | I-cell_type by | O EBV | O . | O,The | O Epstein-Barr | B-protein virus | I-protein protein | I-protein EBNA2 | I-protein acts | O as | O a | O transcriptional | B-protein activator | I-protein of | O cellular | B-DNA and | I-DNA viral | I-DNA genes | I-DNA and | O plays | O a | O crucial | O role | O in | O the | O immortalization | O of | O human | B-cell_type primary | I-cell_type B-cells | I-cell_type by | O EBV | O . | O,False
"Newly translated STAT1 binds in equilibrium fashion to STAT2 and STAT3 , but we show that STAT2 and STAT3 exist in separate heterocomplexes with STAT1 , consistent with a model in which STAT1 contains a common binding site for other STAT proteins .","['STAT1', 'STAT2', 'STAT3', 'STAT2', 'STAT3', 'heterocomplexes', 'STAT1', 'STAT1', 'STAT proteins']","['O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'B-protein', 'O', 'O', 'O', 'B-protein', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O']","['O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","1. STAT1 | True | as it is a protein (protein)
2. STAT2 | True | as it is a protein (protein)
3. STAT3 | True | as it is a protein (protein)
4. heterocomplexes | False | as it is a process
5. binding site | False | as it is a process or a part of a molecule but not a molecule itself",0.5,"Newly | O translated | O STAT1 | B-protein binds | O in | O equilibrium | O fashion | O to | O STAT2 | B-protein and | O STAT3 | B-protein , | O but | O we | O show | O that | O STAT2 | O and | O STAT3 | O exist | O in | O separate | O heterocomplexes | O with | O STAT1 | O , | O consistent | O with | O a | O model | O in | O which | O STAT1 | O contains | O a | O common | O binding | O site | O for | O other | O STAT | O proteins | O . | O","Newly | O translated | O STAT1 | B-protein binds | O in | O equilibrium | O fashion | O to | O STAT2 | B-protein and | O STAT3 | B-protein , | O but | O we | O show | O that | O STAT2 | B-protein and | O STAT3 | B-protein exist | O in | O separate | O heterocomplexes | B-protein with | O STAT1 | B-protein , | O consistent | O with | O a | O model | O in | O which | O STAT1 | B-protein contains | O a | O common | O binding | O site | O for | O other | O STAT | B-protein proteins | I-protein . | O",False
"In addition , a direct correlation exists between the diameter of the PCVs and both the percentage of the OKT8+ T cells ( P less than 0.04 ) and the Leu-7+ natural killer cells ( P less than 0.03 ) .","['OKT8+ T cells', 'natural killer cells']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_line', 'I-cell_line', 'I-cell_line', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'I-cell_type', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'I-cell_type', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'I-cell_type', 'I-cell_type', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","1. PCVs | False | as they are not a protein, DNA, RNA, Cell Type or Cell Line, PCVs refer to packed cell volumes, a measure in hematology
2. OKT8+ T cells | True | as they are a type of cell (cell_type)
3. Leu-7+ natural killer cells | True | as they are a type of cell (cell_type)
4. direct correlation | False | as it is a process or relationship, not a biologically relevant entity
5. diameter | False | as it is a measure, not a biologically relevant entity
6. percentage | False | as it is a measure, not a biologically relevant entity",0.0,"In | O addition | O , | O a | O direct | O correlation | O exists | O between | O the | O diameter | O of | O the | O PCVs | O and | O both | O the | O percentage | O of | O the | O OKT8+ | B-cell_type T | I-cell_type cells | I-cell_type ( | O P | O less | O than | O 0.04 | O ) | O and | O the | O Leu-7+ | B-cell_type natural | I-cell_type killer | I-cell_type cells | I-cell_type ( | O P | O less | O than | O 0.03 | O ) | O . | O","In | O addition | O , | O a | O direct | O correlation | O exists | O between | O the | O diameter | O of | O the | O PCVs | O and | O both | O the | O percentage | O of | O the | O OKT8+ | B-cell_line T | I-cell_line cells | I-cell_line ( | O P | O less | O than | O 0.04 | O ) | O and | O the | O Leu-7+ | O natural | B-cell_type killer | I-cell_type cells | I-cell_type ( | O P | O less | O than | O 0.03 | O ) | O . | O",False
"Except for a 4-hour advancement of the peak , a similar circadian rhythm of hepatic GR was detected in rats reared under a reversed lighting regimen ( 12D : 12L ; lights on between 18 : 30 and 06 : 30 h ) .",['hepatic GR'],"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","1. 4-hour advancement | False | as it is a time concept, not a biological entity.
2. peak | False | as it is a concept related to the measurement of time, not a biological entity.
3. circadian rhythm | False | as it is a biological process, not a biological entity.
4. hepatic GR | True | as ""GR"" stands for Glucocorticoid receptor, which is a protein (protein)
5. rats | False | as they are an animal species (not a protein, group of proteins, DNA, RNA, Cell Type or Cell Line)
6. reversed lighting regimen ( 12D : 12L ; lights on between 18 : 30 and 06 : 30 h ) | False | as it is an experimental setup (not a protein, group of proteins, DNA, RNA, Cell Type or Cell Line)",1.0,"Except | O for | O a | O 4-hour | O advancement | O of | O the | O peak | O , | O a | O similar | O circadian | O rhythm | O of | O hepatic | B-protein GR | I-protein was | O detected | O in | O rats | O reared | O under | O a | O reversed | O lighting | O regimen | O ( | O 12D | O : | O 12L | O ; | O lights | O on | O between | O 18 | O : | O 30 | O and | O 06 | O : | O 30 | O h | O ) | O . | O","Except | O for | O a | O 4-hour | O advancement | O of | O the | O peak | O , | O a | O similar | O circadian | O rhythm | O of | O hepatic | B-protein GR | I-protein was | O detected | O in | O rats | O reared | O under | O a | O reversed | O lighting | O regimen | O ( | O 12D | O : | O 12L | O ; | O lights | O on | O between | O 18 | O : | O 30 | O and | O 06 | O : | O 30 | O h | O ) | O . | O",True
"Several new , clinically relevant compounds dissociate antiproliferative and calcemic activities of 1 , 25 ( OH ) 2D3 , but the molecular basis for this has not been clearly elucidated .",[],"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","1. Compounds | False | as they are chemicals and not a protein, DNA, RNA, cell type or cell line.
2. Antiproliferative | False | as it is an adjective, not an entity.
3. Calcemic activities | False | as this is a biological function, not an entity.
4.1, 25  (OH)2D3 | True | as it is a form of Vitamin D, a protein (protein).
5. Molecular basis | False | as it is a general term, not a specific entity.",0.0,"Several | O new | O , | O clinically | O relevant | O compounds | O dissociate | O antiproliferative | O and | O calcemic | O activities | O of | O 1 | O , | B-protein 25 | I-protein ( | O OH | O ) | O 2D3 | O , | O but | O the | O molecular | O basis | O for | O this | O has | O not | O been | O clearly | O elucidated | O . | O","Several | O new | O , | O clinically | O relevant | O compounds | O dissociate | O antiproliferative | O and | O calcemic | O activities | O of | O 1 | O , | O 25 | O ( | O OH | O ) | O 2D3 | O , | O but | O the | O molecular | O basis | O for | O this | O has | O not | O been | O clearly | O elucidated | O . | O",False
"Surface marker analysis showed that HMBA-induced cells expressed reduced levels of glycophorin A , CD5 , CD7 and CD11b .","['HMBA-induced cells', 'glycophorin A', 'CD5', 'CD7', 'CD11b']","['O', 'O', 'O', 'O', 'O', 'B-cell_line', 'I-cell_line', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O', 'B-protein', 'O', 'B-protein', 'O', 'B-protein', 'O']","['O', 'O', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O', 'B-protein', 'O', 'B-protein', 'O', 'B-protein', 'O']","1. Surface marker analysis | False | as it is a process 
2. HMBA-induced cells | True | they are a modified type of cell (cell_type)
3. glycophorin A | True | as it is a protein (protein)
4. CD5 | True | as it is a protein (protein)
5. CD7 | True | as it is a protein (protein)
6. CD11b | True | as it is a protein (protein)",0.8000000000000002,"Surface | O marker | O analysis | O showed | O that | O HMBA-induced | B-cell_type cells | I-cell_type expressed | O reduced | O levels | O of | O glycophorin | B-protein A | I-protein , | O CD5 | B-protein , | O CD7 | B-protein and | O CD11b | B-protein . | O","Surface | O marker | O analysis | O showed | O that | O HMBA-induced | B-cell_line cells | I-cell_line expressed | O reduced | O levels | O of | O glycophorin | B-protein A | I-protein , | O CD5 | B-protein , | O CD7 | B-protein and | O CD11b | B-protein . | O",False
"In extracts of induced , Il-2 secreting El4 cells three individual protein factors bind to TCEd DNA .","['Il-2 secreting El4 cells', 'protein factors', 'TCEd DNA']","['O', 'O', 'O', 'O', 'O', 'B-cell_line', 'I-cell_line', 'I-cell_line', 'I-cell_line', 'O', 'O', 'B-protein', 'I-protein', 'O', 'O', 'B-DNA', 'I-DNA', 'O']","['O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'B-cell_type', 'I-cell_type', 'O', 'O', 'B-protein', 'I-protein', 'O', 'O', 'B-DNA', 'I-DNA', 'O']","1. Extracts | False | as it is a process
        2. Il-2 | True | as it is a protein (protein)
        3. El4 cells | True | as they are a type of cell (cell_type)
        4. Protein factors | True | as they are proteins (protein)
        5. TCEd DNA | True | as it is DNA (DNA)",0.5714285714285715,"In | O extracts | O of | O induced | O , | O Il-2 | B-protein secreting | O El4 | B-cell_type cells | I-cell_type three | O individual | O protein | B-protein factors | I-protein bind | O to | O TCEd | B-DNA DNA | I-DNA . | O","In | O extracts | O of | O induced | O , | O Il-2 | B-cell_line secreting | I-cell_line El4 | I-cell_line cells | I-cell_line three | O individual | O protein | B-protein factors | I-protein bind | O to | O TCEd | B-DNA DNA | I-DNA . | O",False
"Our observations indicate that changes in the intracellular redox status may be a determining factor in Tax -mediated DNA damage , apoptosis , and selection against the long-term expression of Tax function .","['Tax', 'Tax']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","1. intracellular redox status | False | as this is an abstract concept
2. Tax | True | as it is a type of Human T-cell leukemia virus proteins (protein)
3. DNA damage | False | it's a process rather than an entity according to the given categories
4. apoptosis | False | as it is a process rather than an entity
5. long-term expression | False | as it is an abstract concept
6. Tax function | False | as function of a protein is not an entity.",0.6666666666666666,"Our | O observations | O indicate | O that | O changes | O in | O the | O intracellular | O redox | O status | O may | O be | O a | O determining | O factor | O in | O Tax | B-protein -mediated | O DNA | O damage | O , | O apoptosis | O , | O and | O selection | O against | O the | O long-term | O expression | O of | O Tax | O function | O . | O","Our | O observations | O indicate | O that | O changes | O in | O the | O intracellular | O redox | O status | O may | O be | O a | O determining | O factor | O in | O Tax | B-protein -mediated | O DNA | O damage | O , | O apoptosis | O , | O and | O selection | O against | O the | O long-term | O expression | O of | O Tax | B-protein function | O . | O",False
DLCL represent a heterogeneous group of neoplasms which are treated homogeneously despite the fact that only 50 % of patients experience long-term disease-free survival ( Schneider et al. 1990 ) .,[],"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B-DLBCL', 'O', 'O', 'O', 'O', 'O', 'B-cell_type', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","1. DLCL | True | Diffuse large B-cell lymphoma (DLBCL) is not explicitly mentioned in this context, but DLCL could be a shorthand for that, which makes it a certain type of cell or group of cells (cell_line or cell_type).
   
2. neoplasms | True | This term refers to abnormal cell growths, identifying a type of cell (cell_type).
   
3. Schneider et al. 1990 | False | This is a reference citation, not a protein, group of proteins, DNA, RNA, Cell Type, or Cell Line.

4. patients | False | ""Patients"" is a group of people and does not constitute a protein, group of proteins, DNA, RNA, Cell Type, or Cell Line.

5. disease-free survival | False | This term refers to a state of health or an outcome rather than to a protein, group of proteins, DNA, RNA, Cell Type, or Cell Line.",0.0,DLCL | B-DLBCL represent | O a | O heterogeneous | O group | O of | O neoplasms | B-cell_type which | O are | O treated | O homogeneously | O despite | O the | O fact | O that | O only | O 50 | O % | O of | O patients | O experience | O long-term | O disease-free | O survival | O ( | O Schneider | O et | O al. | O 1990 | O ) | O . | O,DLCL | O represent | O a | O heterogeneous | O group | O of | O neoplasms | O which | O are | O treated | O homogeneously | O despite | O the | O fact | O that | O only | O 50 | O % | O of | O patients | O experience | O long-term | O disease-free | O survival | O ( | O Schneider | O et | O al. | O 1990 | O ) | O . | O,False
IL-10 cooperates with TNF-alpha to activate HIV-1 from latently and acutely infected cells of monocyte/macrophage lineage .,"['IL-10', 'TNF-alpha', 'latently and acutely infected cells', 'monocyte/macrophage lineage']","['B-protein', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'I-cell_type', 'I-cell_type', 'I-cell_type', 'O', 'B-cell_type', 'I-cell_type', 'O']","['B-protein', 'O', 'O', 'B-protein', 'O', 'O', 'B-RNA', 'O', 'B-cell_type', 'I-cell_type', 'I-cell_type', 'I-cell_type', 'I-cell_type', 'I-cell_type', 'I-cell_type', 'I-cell_type', 'O']","1. IL-10 | True | as it is a protein (protein)
   2. TNF-alpha | True | as it is a protein (protein)
   3. HIV-1 | True | a type of RNA virus (RNA)
   4. latently and acutely infected cells of monocyte/macrophage lineage | True | a particular cell state, but the entity here would be the cell type, that is monocyte/macrophage (cell_type) 
   5. Activate | False | as it is a process.",0.5,IL-10 | B-protein cooperates | O with | O TNF-alpha | B-protein to | O activate | O HIV-1 | B-RNA from | O latently | B-cell_type and | I-cell_type acutely | I-cell_type infected | I-cell_type cells | I-cell_type of | I-cell_type monocyte/macrophage | I-cell_type lineage | I-cell_type . | O,IL-10 | B-protein cooperates | O with | O TNF-alpha | B-protein to | O activate | O HIV-1 | O from | O latently | B-cell_type and | I-cell_type acutely | I-cell_type infected | I-cell_type cells | I-cell_type of | O monocyte/macrophage | B-cell_type lineage | I-cell_type . | O,False
"This abnormality was not seen in resting T cells nor T cells from patients with systemic lupus erythematosus , rheumatoid arthritis ( RA ) , or SS accompanied by RA .","['resting T cells', 'T cells']","['O', 'O', 'O', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'I-cell_type', 'O', 'B-cell_type', 'I-cell_type', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","1. abnormality | False | it is a condition or a state which is abstract. 
   2. resting T cells | True | these are inactive T cells and are considered under the cell_type entity
   3. T cells | True | these are a type of white blood cell and fall under the cell_type entity
   4. patients | False | we do not consider patients as entities relevant to the given options 
   5. systemic lupus erythematosus | False | This is considered a disease/condition, not an entity of protein, DNA, RNA, cell_type or cell_line
   6. rheumatoid arthritis ( RA ) | False | This is considered a disease/condition, not an entity of protein, DNA, RNA, cell_type or cell_line 
   7. SS | False | Unclear in this context, it could be an abbreviation for a disease, condition, or protein, but without further information, it is not possible to accurately categorize it.
   8. RA | False | This is an acronym, it is not a protein, DNA, RNA, cell_type or cell_line",0.0,"This | O abnormality | O was | O not | O seen | O in | O resting | O T | O cells | O nor | O T | O cells | O from | O patients | O with | O systemic | O lupus | O erythematosus | O , | O rheumatoid | O arthritis | O ( | O RA | O ) | O , | O or | O SS | O accompanied | O by | O RA | O . | O","This | O abnormality | O was | O not | O seen | O in | O resting | B-cell_type T | I-cell_type cells | I-cell_type nor | O T | B-cell_type cells | I-cell_type from | O patients | O with | O systemic | O lupus | O erythematosus | O , | O rheumatoid | O arthritis | O ( | O RA | O ) | O , | O or | O SS | O accompanied | O by | O RA | O . | O",False
This could partly be explained by the antenatal steroid treatment .,[],"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","1. antenatal steroid treatment | False | as it is a procedure or treatment, not a protein, DNA, RNA, Cell Type or Cell Line.",0.0,This | O could | O partly | O be | O explained | O by | O the | O antenatal | O steroid | O treatment | O . | O,This | O could | O partly | O be | O explained | O by | O the | O antenatal | O steroid | O treatment | O . | O,True
The X-inactivation patterns of circulating PMNCs and T lymphocytes as well as individual granulocyte colonies grown in vitro from bone marrow cells were analyzed .,"['PMNCs', 'T lymphocytes', 'granulocyte colonies']","['O', 'O', 'O', 'O', 'O', 'B-cell_type', 'O', 'B-cell_type', 'I-cell_type', 'O', 'O', 'O', 'O', 'B-cell_line', 'I-cell_line', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B-Peripheral mononuclear cells', 'I-Peripheral mononuclear cells', 'O', 'B-cell_type', 'I-cell_type', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'I-cell_type', 'O', 'O', 'O']","1. X-inactivation patterns | False | as they are a process, not a protein, DNA, RNA, Cell Type or Cell Line
2. circulating PMNCs | True | as PMNCs (Peripheral mononuclear cells) are a type of cell (cell_type)
3. T lymphocytes | True | as they are a type of cell (cell_type)
4. individual granulocyte colonies | False | as colonies represent a group process, not an individual cell type, protein, RNA, or DNA
5. in vitro | False | as this is a setting or condition, not a protein, DNA, RNA, Cell Type or Cell Line 
6. bone marrow cells | True | as they are a type of cell (cell_type)",0.3333333333333333,The | O X-inactivation | O patterns | O of | O circulating | B-Peripheral mononuclear cells PMNCs | I-Peripheral mononuclear cells and | O T | B-cell_type lymphocytes | I-cell_type as | O well | O as | O individual | O granulocyte | O colonies | O grown | O in | O vitro | O from | O bone | B-cell_type marrow | I-cell_type cells | I-cell_type were | O analyzed | O . | O,The | O X-inactivation | O patterns | O of | O circulating | O PMNCs | B-cell_type and | O T | B-cell_type lymphocytes | I-cell_type as | O well | O as | O individual | O granulocyte | B-cell_line colonies | I-cell_line grown | O in | O vitro | O from | O bone | O marrow | O cells | O were | O analyzed | O . | O,False
BACKGROUND : Studies from our laboratory have shown that the earliest stages of atherosclerosis may be mediated by an autoimmune reaction against heat shock protein 60 ( Hsp60 ) .,"['heat shock protein 60', 'Hsp60']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'I-protein', 'O', 'B-protein', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'I-protein', 'O', 'O', 'O', 'O']","1. Studies | False | as they are a conceptual description and not an entity.
2. Laboratory | False | It is a facility for scientific research, not a protein, DNA, RNA, Cell Type, or Cell Line.
3. Earliest stages of atherosclerosis | False | This is a description of a disease state, not an entity.
4. Autoimmune reaction | False | This is a process, not an entity.
5. Heat shock protein 60 ( Hsp60 ) | True | This is a protein (protein).",0.6666666666666666,BACKGROUND | O : | O Studies | O from | O our | O laboratory | O have | O shown | O that | O the | O earliest | O stages | O of | O atherosclerosis | O may | O be | O mediated | O by | O an | O autoimmune | O reaction | O against | O heat | B-protein shock | I-protein protein | I-protein 60 | I-protein ( | O Hsp60 | O ) | O . | O,BACKGROUND | O : | O Studies | O from | O our | O laboratory | O have | O shown | O that | O the | O earliest | O stages | O of | O atherosclerosis | O may | O be | O mediated | O by | O an | O autoimmune | O reaction | O against | O heat | B-protein shock | I-protein protein | I-protein 60 | I-protein ( | O Hsp60 | B-protein ) | O . | O,False
Twenty-two differences from the human sequence were found in the N-terminal region ( amino acids 1-421 ) of the squirrel monkey receptor .,"['N-terminal region', 'amino acids 1-421']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O', 'B-protein', 'I-protein', 'I-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B-DNA or RNA', 'I-DNA or RNA', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","1. human sequence | True | as it is an implied reference to the human DNA or RNA sequence (DNA or RNA)
2. N-terminal region | False | as it is a part of a protein or peptide, but the specific protein or peptide is not given here.
3. amino acids 1-421 | True | as it refers to a specific portion of a protein or peptide sequence (protein)
4. the squirrel monkey receptor | False | as it is too vague and not specific enough to be identified as a particular protein, cell type, or cell line. It would need a more specific name to qualify as an entity.",0.5,Twenty-two | O differences | O from | O the | O human | B-DNA or RNA sequence | I-DNA or RNA were | O found | O in | O the | O N-terminal | O region | O ( | O amino | B-protein acids | I-protein 1-421 | I-protein ) | O of | O the | O squirrel | O monkey | O receptor | O . | O,Twenty-two | O differences | O from | O the | O human | O sequence | O were | O found | O in | O the | O N-terminal | B-protein region | I-protein ( | O amino | B-protein acids | I-protein 1-421 | I-protein ) | O of | O the | O squirrel | O monkey | O receptor | O . | O,False
"Furthermore , P-LPS-induced expression of the MCP-1 gene in the cells also was blocked by inhibitors of two transcription factors , i.e. , curcumin , an inhibitor of AP-1 , and pyrolidine dithiocarbamate , an inhibitor of NF-kappaB .","['MCP-1 gene', 'transcription factors', 'AP-1', 'NF-kappaB']","['O', 'O', 'O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O']","1. P-LPS | True | It's a derivative of Lipopolysaccharide which is a protein (protein)
2. MCP-1 gene | True | as it is a DNA (DNA)
3. cells | False | without specifying a certain kind of cell, this term is too broad to be categorized as an entity
4. transcription factors | False | without specifying which, this term is too broad to be classified as an entity
5. curcumin | False | as it is a chemical compound not a protein, DNA, RNA, Cell Type or Cell Line
6. AP-1 | True | as it is a type of transcription factor, which is a protein (protein)
7. pyrolidine dithiocarbamate | False | as it is a chemical compound, not a protein, DNA, RNA, Cell Type or Cell Line
8. NF-kappaB | True | It's a protein involved in DNA transcription (protein)",0.8571428571428571,"Furthermore | O , | O P-LPS-induced | O expression | O of | O the | O MCP-1 | B-DNA gene | I-DNA in | O the | O cells | O also | O was | O blocked | O by | O inhibitors | O of | O two | O transcription | O factors | O , | O i.e. | O , | O curcumin | O , | O an | O inhibitor | O of | O AP-1 | B-protein , | O and | O pyrolidine | O dithiocarbamate | O , | O an | O inhibitor | O of | O NF-kappaB | B-protein . | O","Furthermore | O , | O P-LPS-induced | O expression | O of | O the | O MCP-1 | B-DNA gene | I-DNA in | O the | O cells | O also | O was | O blocked | O by | O inhibitors | O of | O two | O transcription | B-protein factors | I-protein , | O i.e. | O , | O curcumin | O , | O an | O inhibitor | O of | O AP-1 | B-protein , | O and | O pyrolidine | O dithiocarbamate | O , | O an | O inhibitor | O of | O NF-kappaB | B-protein . | O",False
"At present , it is unclear whether the lack of PU.1 expression and activity in human multiple myeloma cell lines represents a malignancy-associated defect in these cells or exemplifies a normal developmental regulation in terminally differentiated B cells .","['PU.1', 'human multiple myeloma cell lines', 'terminally differentiated B cells']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'B-cell_line', 'I-cell_line', 'I-cell_line', 'I-cell_line', 'I-cell_line', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'I-cell_type', 'I-cell_type', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'B-cell_line', 'I-cell_line', 'I-cell_line', 'I-cell_line', 'I-cell_line', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'I-cell_type', 'I-cell_type', 'O']","1. PU.1 | True | as it is a type of protein (protein)
2. Human multiple myeloma cell lines | True | as they are a type of cell line (cell_line)
3. Cells | False | While cells are a general concept, in this context it is too generic and does not specify a specific cell type or cell line.
4. Normal developmental regulation | False | as it is a process 
5. Terminally differentiated B cells | True | as they are a type of cell (cell_type)",1.0,"At | O present | O , | O it | O is | O unclear | O whether | O the | O lack | O of | O PU.1 | B-protein expression | O and | O activity | O in | O human | B-cell_line multiple | I-cell_line myeloma | I-cell_line cell | I-cell_line lines | I-cell_line represents | O a | O malignancy-associated | O defect | O in | O these | O cells | O or | O exemplifies | O a | O normal | O developmental | O regulation | O in | O terminally | B-cell_type differentiated | I-cell_type B | I-cell_type cells | I-cell_type . | O","At | O present | O , | O it | O is | O unclear | O whether | O the | O lack | O of | O PU.1 | B-protein expression | O and | O activity | O in | O human | B-cell_line multiple | I-cell_line myeloma | I-cell_line cell | I-cell_line lines | I-cell_line represents | O a | O malignancy-associated | O defect | O in | O these | O cells | O or | O exemplifies | O a | O normal | O developmental | O regulation | O in | O terminally | B-cell_type differentiated | I-cell_type B | I-cell_type cells | I-cell_type . | O",True
There was a significant positive correlation between VDR concentration and serum phosphate ( P less than 0.05 ) .,['VDR'],"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-Vitamin D Receptor', 'I-Vitamin D Receptor', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","1. VDR concentration | True | as VDR (Vitamin D Receptor) is a protein (protein).
   2. serum phosphate | False | as it is a mixture and not a protein, DNA, RNA, Cell type or Cell Line.
   3. P less than 0.05 | False | as it is a statistical expression and not an entity.",0.0,There | O was | O a | O significant | O positive | O correlation | O between | O VDR | B-Vitamin D Receptor concentration | I-Vitamin D Receptor and | O serum | O phosphate | O ( | O P | O less | O than | O 0.05 | O ) | O . | O,There | O was | O a | O significant | O positive | O correlation | O between | O VDR | B-protein concentration | O and | O serum | O phosphate | O ( | O P | O less | O than | O 0.05 | O ) | O . | O,False
We also observed the induction of the myelomonocytic specific tyrosine kinase hck gene simultaneously with the other immediate early response genes .,"['myelomonocytic specific tyrosine kinase hck gene', 'immediate early response genes']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'I-DNA', 'I-DNA', 'I-DNA', 'I-DNA', 'O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'I-DNA', 'I-DNA', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-gene refers to DNA', 'I-gene refers to DNA', 'I-gene refers to DNA', 'I-gene refers to DNA', 'I-gene refers to DNA', 'I-gene refers to DNA', 'O', 'O', 'O', 'O', 'B-gene refers to DNA', 'I-gene refers to DNA', 'I-gene refers to DNA', 'I-gene refers to DNA', 'O']","1. myelomonocytic specific tyrosine kinase hck gene | True | as it is a protein-encoding gene (gene refers to DNA)
2. immediate early response genes | True | as it refers to a group of genes (gene refers to DNA)
3. Induction | False | as it is a process not a protein, DNA, RNA, Cell Type or Cell Line.",0.0,We | O also | O observed | O the | O induction | O of | O the | O myelomonocytic | B-gene refers to DNA specific | I-gene refers to DNA tyrosine | I-gene refers to DNA kinase | I-gene refers to DNA hck | I-gene refers to DNA gene | I-gene refers to DNA simultaneously | O with | O the | O other | O immediate | B-gene refers to DNA early | I-gene refers to DNA response | I-gene refers to DNA genes | I-gene refers to DNA . | O,We | O also | O observed | O the | O induction | O of | O the | O myelomonocytic | B-DNA specific | I-DNA tyrosine | I-DNA kinase | I-DNA hck | I-DNA gene | I-DNA simultaneously | O with | O the | O other | O immediate | B-DNA early | I-DNA response | I-DNA genes | I-DNA . | O,False
"Given the role of this transcription factor in the regulation of gene expression in the inflammatory response , NF-kappaB inhibitors have been suggested as potential therapeutic drugs for inflammatory diseases .",['NF-kappaB'],"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","1. transcription factor | True | as it's a specific type of protein that controls the rate of transcription of genetic information (protein)
2. gene | False | even though it's genetic material, specifics about its nature (e.g., type of gene) are not provided
3. inflammatory response | False | as it is a physiological process
4. NF-kappaB inhibitors | True | these are proteins that inhibit NF-kappaB, another protein (protein)
5. therapeutic drugs | False | as they are broad categories of compounds, not specific entities
6. inflammatory diseases | False | these are health conditions, not specific entities
",0.0,"Given | O the | O role | O of | O this | O transcription | B-protein factor | I-protein in | O the | O regulation | O of | O gene | O expression | O in | O the | O inflammatory | O response | O , | O NF-kappaB | B-protein inhibitors | I-protein have | O been | O suggested | O as | O potential | O therapeutic | O drugs | O for | O inflammatory | O diseases | O . | O","Given | O the | O role | O of | O this | O transcription | O factor | O in | O the | O regulation | O of | O gene | O expression | O in | O the | O inflammatory | O response | O , | O NF-kappaB | B-protein inhibitors | O have | O been | O suggested | O as | O potential | O therapeutic | O drugs | O for | O inflammatory | O diseases | O . | O",False
"We have previously shown that the presence of the CD4 cytoplasmic tail is critical for human immunodeficiency virus ( HIV ) -induced apoptosis ( J.Corbeil , M.Tremblay , and D.D.Richman , J.Exp.Med.183 : 39-48 , 1996 ) .",['CD4 cytoplasmic tail'],"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'O', 'O', 'O', 'B-DNA/RNA', 'I-DNA/RNA', 'I-DNA/RNA', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","1. CD4 cytoplasmic tail | True | as it is a part of the CD4 protein (protein)
2. human immunodeficiency virus ( HIV ) | True | as it is a type of virus, containing specific DNA or RNA (DNA/RNA)
3. apoptosis | False | as it is a process
4. J.Corbeil, M.Tremblay, and D.D.Richman | False | as they are names of researchers, not an entity
5. J.Exp.Med.183: 39-48, 1996 | False | as it is a citation/reference, not an entity.",0.6666666666666666,"We | O have | O previously | O shown | O that | O the | O presence | O of | O the | O CD4 | B-protein cytoplasmic | I-protein tail | I-protein is | O critical | O for | O human | B-DNA/RNA immunodeficiency | I-DNA/RNA virus | I-DNA/RNA ( | O HIV | O ) | O -induced | O apoptosis | O ( | O J.Corbeil | O , | O M.Tremblay | O , | O and | O D.D.Richman | O , | O J.Exp.Med.183 | O : | O 39-48 | O , | O 1996 | O ) | O . | O","We | O have | O previously | O shown | O that | O the | O presence | O of | O the | O CD4 | B-protein cytoplasmic | I-protein tail | I-protein is | O critical | O for | O human | O immunodeficiency | O virus | O ( | O HIV | O ) | O -induced | O apoptosis | O ( | O J.Corbeil | O , | O M.Tremblay | O , | O and | O D.D.Richman | O , | O J.Exp.Med.183 | O : | O 39-48 | O , | O 1996 | O ) | O . | O",False
"Hence , Ca2+ binds to calmodulin , leading to the binding of calmodulin to calcineurin ; the activated calcineurin , in turn , may dephosphorylate the cytoplasmic subunit of NF-AT , resulting in its translocation from the cytoplasm into the nucleus to form a competent transcriptional activator .","['calmodulin', 'calmodulin', 'calcineurin', 'calcineurin', 'cytoplasmic subunit of NF-AT', 'competent transcriptional activator']","['O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'B-protein', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'I-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'O']","['O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'I-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","1. Ca2+ | False | Calcium ions are a chemical substance but not a protein, DNA, RNA, Cell Type or Cell Line
2. calmodulin | True | Calmodulin is a calcium-binding protein (protein)
3. calcineurin | True | Calcineurin is a calcium and calmodulin dependent serine/threonine protein phosphatase (protein)
4. cytoplasmic subunit of NF-AT | True | NF-AT is a protein (protein)
5. nucleus | False | Although nucleus is a cellular structure, it is not categorized as cell type or cell line.
6. transcriptional activator | False | Transcriptional activator is a kind of regulating protein but it is too generic here and lacks specific name. Hence, it cannot be considered as an entity here.",0.6666666666666666,"Hence | O , | O Ca2+ | O binds | O to | O calmodulin | B-protein , | O leading | O to | O the | O binding | O of | O calmodulin | O to | O calcineurin | B-protein ; | O the | O activated | O calcineurin | O , | O in | O turn | O , | O may | O dephosphorylate | O the | O cytoplasmic | B-protein subunit | I-protein of | I-protein NF-AT | I-protein , | O resulting | O in | O its | O translocation | O from | O the | O cytoplasm | O into | O the | O nucleus | O to | O form | O a | O competent | O transcriptional | O activator | O . | O","Hence | O , | O Ca2+ | O binds | O to | O calmodulin | B-protein , | O leading | O to | O the | O binding | O of | O calmodulin | B-protein to | O calcineurin | B-protein ; | O the | O activated | O calcineurin | B-protein , | O in | O turn | O , | O may | O dephosphorylate | O the | O cytoplasmic | B-protein subunit | I-protein of | I-protein NF-AT | I-protein , | O resulting | O in | O its | O translocation | O from | O the | O cytoplasm | O into | O the | O nucleus | O to | O form | O a | O competent | B-protein transcriptional | I-protein activator | I-protein . | O",False
"We further demonstrated that IL-2 , -7 , and -15 induce multiple STAT proteins , including STAT5a , STAT5b , STAT1 alpha , STAT3 , and another unidentified Fc gamma RI GAS DNA-binding protein .","['IL-2 , -7 , and -15', 'multiple STAT proteins', 'STAT5a', 'STAT5b', 'STAT1 alpha', 'STAT3', 'Fc gamma RI GAS DNA-binding protein']","['O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'I-protein', 'I-protein', 'I-protein', 'O', 'B-protein', 'I-protein', 'I-protein', 'O', 'O', 'B-protein', 'O', 'B-protein', 'O', 'B-protein', 'I-protein', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'I-protein', 'I-protein', 'I-protein', 'O']","['O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O', 'O', 'B-protein', 'O', 'B-protein', 'O', 'B-protein', 'I-protein', 'O', 'B-protein', 'O', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'I-protein', 'I-protein', 'I-protein', 'I-protein', 'O']","1. IL-2 | True | as it is a protein (protein)
   2. IL-7 | True | as it is a protein (protein)
   3. IL-15 | True | as it is a protein (protein)
   4. STAT proteins | True | as they are a group of proteins (protein)
   5. STAT5a | True | as it is a protein (protein)
   6. STAT5b | True | as it is a protein (protein)
   7. STAT1 alpha | True | as it is a protein (protein)
   8. STAT3 | True | as it is a protein (protein)
   9. unidentified Fc gamma RI GAS DNA-binding protein | True | as it is mentioned as a protein, but unidentified (protein)
   10. DNA-binding protein | False | as this is more of a generic categorization, not a specific entity.",0.5714285714285714,"We | O further | O demonstrated | O that | O IL-2 | B-protein , | O -7 | O , | O and | O -15 | O induce | O multiple | O STAT | B-protein proteins | I-protein , | O including | O STAT5a | B-protein , | O STAT5b | B-protein , | O STAT1 | B-protein alpha | I-protein , | O STAT3 | B-protein , | O and | O another | O unidentified | B-protein Fc | I-protein gamma | I-protein RI | I-protein GAS | I-protein DNA-binding | I-protein protein | I-protein . | O","We | O further | O demonstrated | O that | O IL-2 | B-protein , | I-protein -7 | I-protein , | I-protein and | I-protein -15 | I-protein induce | O multiple | B-protein STAT | I-protein proteins | I-protein , | O including | O STAT5a | B-protein , | O STAT5b | B-protein , | O STAT1 | B-protein alpha | I-protein , | O STAT3 | B-protein , | O and | O another | O unidentified | O Fc | B-protein gamma | I-protein RI | I-protein GAS | I-protein DNA-binding | I-protein protein | I-protein . | O",False
"In the T cell line CTLL2 , ligation of kit/IL-4R alpha induces cellular proliferation .","['T cell line CTLL2', 'kit/IL-4R alpha']","['O', 'O', 'B-cell_line', 'I-cell_line', 'I-cell_line', 'I-cell_line', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O', 'O', 'O', 'O']","1. T-cell line CTLL2 | True | as it is a cell line (cell_line) 
2. Kit/IL-4R alpha | True | as it denotes a combination of proteins (protein)
3. Cellular proliferation | False | as it is a biological process which does not fit the criteria for a protein, DNA, RNA, cell type, or cell line.",0.6666666666666666,"In | O the | O T | O cell | O line | O CTLL2 | O , | O ligation | O of | O kit/IL-4R | B-protein alpha | I-protein induces | O cellular | O proliferation | O . | O","In | O the | O T | B-cell_line cell | I-cell_line line | I-cell_line CTLL2 | I-cell_line , | O ligation | O of | O kit/IL-4R | B-protein alpha | I-protein induces | O cellular | O proliferation | O . | O",False
"A motif presenting a strong similarity to an initiator was detected , as well as putative binding sites for Sp1 , GATA-2 , LyF-1 , ets-1 , AP1 , and MZF1 transcription factors , and two GAS motifs .","['putative binding sites', 'Sp1', 'GATA-2', 'LyF-1', 'ets-1', 'AP1', 'MZF1', 'transcription factors', 'GAS motifs']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'I-DNA', 'O', 'B-protein', 'O', 'B-protein', 'O', 'B-protein', 'O', 'B-protein', 'O', 'B-protein', 'O', 'O', 'B-protein', 'B-protein', 'I-protein', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'B-protein', 'O', 'B-protein', 'O', 'B-protein', 'O', 'B-protein', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","1. A motif | False | as it is an abstract concept
2. initiator | False | as it is a process or role, not a specific protein, DNA, RNA, Cell Type or Cell Line
3. putative binding sites | False | it's a term referring to a location on a molecule where a protein can bind, but not a specific protein, DNA, RNA, Cell Type or Cell Line
4. Sp1 | True | as it is a transcription factor protein (protein)
5. GATA-2 | True | as it is a transcription factor protein (protein)
6. LyF-1 | True | as it is a transcription factor protein (protein)
7. ets-1 | True | as it is a transcription factor protein (protein)
8. AP1 | True | as it is a transcription factor protein (protein)
9. MZF1 | True | as it is a transcription factor protein (protein)
10. transcription factors | False | as it is an abstract concept covering a group of proteins, but not a specific protein, DNA, RNA, Cell Type or Cell Line
11. GAS motifs | False | as it is an abstract concept pertaining to specific motifs (sequence patterns), not a specific protein, DNA, RNA, Cell Type or Cell Line.",0.8,"A | O motif | O presenting | O a | O strong | O similarity | O to | O an | O initiator | O was | O detected | O , | O as | O well | O as | O putative | O binding | O sites | O for | O Sp1 | B-protein , | O GATA-2 | B-protein , | O LyF-1 | B-protein , | O ets-1 | B-protein , | O AP1 | B-protein , | O and | O MZF1 | B-protein transcription | O factors | O , | O and | O two | O GAS | O motifs | O . | O","A | O motif | O presenting | O a | O strong | O similarity | O to | O an | O initiator | O was | O detected | O , | O as | O well | O as | O putative | B-DNA binding | I-DNA sites | I-DNA for | O Sp1 | B-protein , | O GATA-2 | B-protein , | O LyF-1 | B-protein , | O ets-1 | B-protein , | O AP1 | B-protein , | O and | O MZF1 | B-protein transcription | B-protein factors | I-protein , | O and | O two | O GAS | B-DNA motifs | I-DNA . | O",False
Transcriptional activation of the HIV enhancer was also subject to regulation by recently cloned I kappa B-alpha ( MAD-3 ) .,"['I kappa B-alpha', 'MAD-3']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'O', 'B-protein', 'O', 'O']","['O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'O', 'O', 'O', 'O']","1. Transcriptional activation | False | as it is a process
2. HIV enhancer | True | as it is a DNA (DNA)
3. I kappa B-alpha ( MAD-3 ) | True | as it is a protein (protein)",0.5,Transcriptional | O activation | O of | O the | O HIV | B-DNA enhancer | I-DNA was | O also | O subject | O to | O regulation | O by | O recently | O cloned | O I | B-protein kappa | I-protein B-alpha | I-protein ( | O MAD-3 | O ) | O . | O,Transcriptional | O activation | O of | O the | O HIV | O enhancer | O was | O also | O subject | O to | O regulation | O by | O recently | O cloned | O I | B-protein kappa | I-protein B-alpha | I-protein ( | O MAD-3 | B-protein ) | O . | O,False
"In addition , sodium salicylate and additional NSAIDs used at concentrations that activate HSF1 also inhibited the expression of other monocytic genes ( TNF-alpha , IL-1beta , IL-6 , IL-8 , IL-10 , ICAM-1 ) activated by exposure to a pro-inflammatory stimulus ( lipopolysaccharide , LPS ) .","['HSF1', 'monocytic genes', 'TNF-alpha', 'IL-1beta', 'IL-6', 'IL-8', 'IL-10', 'ICAM-1']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'O', 'B-DNA', 'O', 'B-DNA', 'O', 'B-DNA', 'O', 'B-DNA', 'O', 'B-DNA', 'O', 'B-DNA', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-heat shock transcription factor 1', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'Tumor necrosis factor-alpha', 'O', 'B-Interleukin 1 Beta', 'O', 'B-Interleukin 6', 'O', 'B-Interleukin 8', 'O', 'B-Interleukin 10', 'O', 'B-Intercellular Adhesion Molecule 1', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","1. sodium salicylate | False | as it is a drug, not a protein, DNA, RNA, Cell Type or Cell Line.
2. NSAIDs | False | as it stands for nonsteroidal anti-inflammatory drugs and is not a protein, DNA, RNA, Cell Type or Cell Line.
3. HSF1 | True | as it is a protein (heat shock transcription factor 1).
4. monocytic genes | False | as they are not specific DNA, they are just a category.
5. TNF-alpha | True | as it is a protein (Tumor necrosis factor-alpha).
6. IL-1beta | True | as it is a protein (Interleukin 1 Beta).
7. IL-6 | True | as it is a protein (Interleukin 6).
8. IL-8 | True | as it is a protein (Interleukin 8).
9. IL-10 | True | as it is a protein (Interleukin 10).
10. ICAM-1 | True | as it is a protein (Intercellular Adhesion Molecule 1).
11. pro-inflammatory stimulus | False | as it is a process, not an entity.
12. lipopolysaccharide, LPS | False | as it is a component of the outer membrane of Gram-negative bacteria and not a DNA, RNA, protein, cell type or cell line.",0.0,"In | O addition | O , | O sodium | O salicylate | O and | O additional | O NSAIDs | O used | O at | O concentrations | O that | O activate | O HSF1 | B-heat shock transcription factor 1 also | O inhibited | O the | O expression | O of | O other | O monocytic | O genes | O ( | O TNF-alpha | Tumor necrosis factor-alpha , | O IL-1beta | B-Interleukin 1 Beta , | O IL-6 | B-Interleukin 6 , | O IL-8 | B-Interleukin 8 , | O IL-10 | B-Interleukin 10 , | O ICAM-1 | B-Intercellular Adhesion Molecule 1 ) | O activated | O by | O exposure | O to | O a | O pro-inflammatory | O stimulus | O ( | O lipopolysaccharide | O , | O LPS | O ) | O . | O","In | O addition | O , | O sodium | O salicylate | O and | O additional | O NSAIDs | O used | O at | O concentrations | O that | O activate | O HSF1 | B-protein also | O inhibited | O the | O expression | O of | O other | O monocytic | B-DNA genes | I-DNA ( | O TNF-alpha | B-DNA , | O IL-1beta | B-DNA , | O IL-6 | B-DNA , | O IL-8 | B-DNA , | O IL-10 | B-DNA , | O ICAM-1 | B-DNA ) | O activated | O by | O exposure | O to | O a | O pro-inflammatory | O stimulus | O ( | O lipopolysaccharide | O , | O LPS | O ) | O . | O",False
Functional IL-12 is a heterodimer composed of two distinct subunits that are encoded by separate genes on different chromosomes .,"['IL-12', 'heterodimer']","['O', 'B-protein', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'O', 'B-DNA', 'I-DNA', 'O']","1. Functional IL-12 | False | This is a protein (protein), but the term ""functional"" is used to describe an attribute or condition of the protein, not the protein itself.
2. heterodimer | False | This is a term describing a molecular structure, not a specific protein, DNA, RNA, Cell Type or Cell Line.
3. two distinct subunits | False | This is a description of a structure, not a specific protein, DNA, RNA, Cell Type or Cell Line.
4. separate genes | True | These are a form of DNA (DNA).
5. different chromosomes | True | Chromosomes are structures that contain DNA (DNA).",0.0,Functional | O IL-12 | O is | O a | O heterodimer | O composed | O of | O two | O distinct | O subunits | O that | O are | O encoded | O by | O separate | B-DNA genes | I-DNA on | O different | B-DNA chromosomes | I-DNA . | O,Functional | O IL-12 | B-protein is | O a | O heterodimer | B-protein composed | O of | O two | O distinct | O subunits | O that | O are | O encoded | O by | O separate | O genes | O on | O different | O chromosomes | O . | O,False
Arg551 was not associated with atopic asthma in the Japanese population .,[],"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","1. Arg551 | True | as it is a protein (protein)
2. atopic asthma | False | as it is a condition or disease, not a protein, DNA, RNA, Cell Type or Cell Line
3. Japanese population | False | as it is a group of people, not a protein, DNA, RNA, Cell Type or Cell Line.",0.0,Arg551 | B-protein was | O not | O associated | O with | O atopic | O asthma | O in | O the | O Japanese | O population | O . | O,Arg551 | O was | O not | O associated | O with | O atopic | O asthma | O in | O the | O Japanese | O population | O . | O,False
"In the culture system reported here , ( 1 ) the growth factor ( GF ) stimulus induces cord blood ( CB ) progenitor cells to proliferate and differentiate/mature exclusively along the erythroid lineage ; ( 2 ) this erythropoietic wave is characterized by less than 4 % apoptotic cells ; ( 3 ) asymmetric divisions are virtually absent , ie , nonresponsive hematopoietic progenitors with no erythropoietic potential are forced into apoptosis ; ( 4 ) the system is cell division controlled ( cdc ) , ie , the number of divisions performed by each cell is monitored .","['growth factor', 'GF', 'cord blood ( CB ) progenitor cells', 'erythroid lineage', 'hematopoietic progenitors']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O', 'B-protein', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'I-cell_type', 'I-cell_type', 'I-cell_type', 'I-cell_type', 'I-cell_type', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O', 'O', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'I-cell_type', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","1. culture system | False | as it is not a protein, DNA, RNA, Cell Type or Cell Line
2. growth factor ( GF ) | True | as it is a protein (protein)
3. cord blood ( CB ) progenitor cells | True | as they are a type of cell (cell_type)
4. erythroid lineage | False | as it is not a protein, DNA, RNA, Cell Type or Cell it's a classification or lineage of cells
5. apoptotic cells | True | as they are a type of cell (cell_type)
6. nonresponsive hematopoietic progenitors | True | as they are a type of cell (cell_type)
7. erythropoietic potential | False | as it is an abstract concept rather than a protein, DNA, RNA, Cell Type or Cell Line
8. cell division controlled ( cdc ) | False | as it is a process.
9. number of divisions | False | as it is a quantitative measurement.",0.2222222222222222,"In | O the | O culture | O system | O reported | O here | O , | O ( | O 1 | O ) | O the | O growth | B-protein factor | I-protein ( | O GF | O ) | O stimulus | O induces | O cord | B-cell_type blood | I-cell_type ( | O CB | O ) | O progenitor | O cells | O to | O proliferate | O and | O differentiate/mature | O exclusively | O along | O the | O erythroid | O lineage | O ; | O ( | O 2 | O ) | O this | O erythropoietic | O wave | O is | O characterized | O by | O less | O than | O 4 | O % | O apoptotic | B-cell_type cells | I-cell_type ; | O ( | O 3 | O ) | O asymmetric | O divisions | O are | O virtually | O absent | O , | O ie | O , | O nonresponsive | B-cell_type hematopoietic | I-cell_type progenitors | I-cell_type with | O no | O erythropoietic | O potential | O are | O forced | O into | O apoptosis | O ; | O ( | O 4 | O ) | O the | O system | O is | O cell | O division | O controlled | O ( | O cdc | O ) | O , | O ie | O , | O the | O number | O of | O divisions | O performed | O by | O each | O cell | O is | O monitored | O . | O","In | O the | O culture | O system | O reported | O here | O , | O ( | O 1 | O ) | O the | O growth | B-protein factor | I-protein ( | O GF | B-protein ) | O stimulus | O induces | O cord | B-cell_type blood | I-cell_type ( | I-cell_type CB | I-cell_type ) | I-cell_type progenitor | I-cell_type cells | I-cell_type to | O proliferate | O and | O differentiate/mature | O exclusively | O along | O the | O erythroid | B-cell_type lineage | I-cell_type ; | O ( | O 2 | O ) | O this | O erythropoietic | O wave | O is | O characterized | O by | O less | O than | O 4 | O % | O apoptotic | O cells | O ; | O ( | O 3 | O ) | O asymmetric | O divisions | O are | O virtually | O absent | O , | O ie | O , | O nonresponsive | O hematopoietic | B-cell_type progenitors | I-cell_type with | O no | O erythropoietic | O potential | O are | O forced | O into | O apoptosis | O ; | O ( | O 4 | O ) | O the | O system | O is | O cell | O division | O controlled | O ( | O cdc | O ) | O , | O ie | O , | O the | O number | O of | O divisions | O performed | O by | O each | O cell | O is | O monitored | O . | O",False
In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1 .,"['B cells', 'metalloproteinases-1']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'O', 'O', 'O', 'O', 'B-protein', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'O', 'B-protein', 'I-protein', 'I-protein', 'I-protein', 'O']","1. In vitro | False | as it is a procedural term used in biology, not a protein, DNA, RNA, Cell Type or Cell Line. 
2. programmed cell death | False | as it is a biological process not a protein, DNA, RNA, Cell Type or Cell Line.
3. B cells | True | as they are a type of cell (cell_type). 
4. tissue inhibitor of metalloproteinases-1 | True | as it is a protein (protein).",0.5,In | O vitro | O suppression | O of | O programmed | O cell | O death | O of | O B | B-cell_type cells | I-cell_type by | O tissue | B-protein inhibitor | I-protein of | I-protein metalloproteinases-1 | I-protein . | O,In | O vitro | O suppression | O of | O programmed | O cell | O death | O of | O B | B-cell_type cells | I-cell_type by | O tissue | O inhibitor | O of | O metalloproteinases-1 | B-protein . | O,False
"NF-kappa B activation was independent of the transmembrane domain of CD40 , suggesting that it is independent of p23 , a molecule that associates with CD40 in a region other than the cytoplasmic domain .","['NF-kappa B', 'transmembrane domain', 'CD40', 'p23', 'CD40', 'cytoplasmic domain']","['B-protein', 'I-protein', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O']","['B-protein', 'I-protein', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'I-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O']","1. NF-kappa B | True | It is a protein transcription factor (protein).
2. transmembrane domain of CD40 | True | This term refers to a characteristic of the protein CD40 (protein).
3. p23 | True | It is a protein (protein).
4. CD40 | True | It is a protein (protein).
5. region | False | A region is not one of the entities (it's not a protein, DNA, RNA, cell type or cell line).
6. cytoplasmic domain | True | It is a part of a protein, hence it can be considered an entity (protein).",0.6,"NF-kappa | B-protein B | I-protein activation | O was | O independent | O of | O the | O transmembrane | B-protein domain | I-protein of | I-protein CD40 | I-protein , | O suggesting | O that | O it | O is | O independent | O of | O p23 | B-protein , | O a | O molecule | O that | O associates | O with | O CD40 | O in | O a | O region | O other | O than | O the | O cytoplasmic | B-protein domain | I-protein . | O","NF-kappa | B-protein B | I-protein activation | O was | O independent | O of | O the | O transmembrane | B-protein domain | I-protein of | O CD40 | B-protein , | O suggesting | O that | O it | O is | O independent | O of | O p23 | B-protein , | O a | O molecule | O that | O associates | O with | O CD40 | B-protein in | O a | O region | O other | O than | O the | O cytoplasmic | B-protein domain | I-protein . | O",False
Here we demonstrate that the putative GAS element in the CAEV LTR binds specifically to a cellular factor induced by IFN-gamma in promonocytic cells .,"['GAS element', 'CAEV LTR', 'cellular factor', 'IFN-gamma', 'promonocytic cells']","['O', 'O', 'O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'O', 'O', 'B-DNA', 'I-DNA', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O', 'O', 'B-protein', 'O', 'B-cell_type', 'I-cell_type', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'O', 'O', 'B-DNA', 'I-DNA', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O', 'O', 'B-protein', 'O', 'B-cell_type', 'I-cell_type', 'O']","1. GAS element | True | as it is a DNA sequence (DNA)
2. CAEV LTR | True | as it is a part of a retrovirus genome (DNA)
3. cellular factor | True | as it refers to a protein that might be induced in the cell depending on certain conditions (protein) 
4. IFN-gamma | True | as it is an interferon protein (protein)
5. promonocytic cells | True | as the term refers to a cell type (cell_type)",1.0,Here | O we | O demonstrate | O that | O the | O putative | O GAS | B-DNA element | I-DNA in | O the | O CAEV | B-DNA LTR | I-DNA binds | O specifically | O to | O a | O cellular | B-protein factor | I-protein induced | O by | O IFN-gamma | B-protein in | O promonocytic | B-cell_type cells | I-cell_type . | O,Here | O we | O demonstrate | O that | O the | O putative | O GAS | B-DNA element | I-DNA in | O the | O CAEV | B-DNA LTR | I-DNA binds | O specifically | O to | O a | O cellular | B-protein factor | I-protein induced | O by | O IFN-gamma | B-protein in | O promonocytic | B-cell_type cells | I-cell_type . | O,True
"Allergen-specific T cells in atopic patients are polarized IL-4-producing Th2 cells , promoting IgE synthesis by B cells .","['T cells', 'IL-4-producing Th2 cells', 'IgE', 'B cells']","['O', 'B-cell_type', 'I-cell_type', 'O', 'O', 'O', 'O', 'O', 'B-cell_line', 'I-cell_line', 'I-cell_line', 'O', 'O', 'B-protein', 'O', 'O', 'B-cell_type', 'I-cell_type', 'O']","['B-cell_type', 'I-cell_type', 'I-cell_type', 'O', 'O', 'O', 'O', 'O', 'B-protein, cell_type', 'I-protein, cell_type', 'I-protein, cell_type', 'O', 'O', 'B-IgE', 'O', 'O', 'B-cell_type', 'I-cell_type', 'O']","1. Allergen-specific T cells | True | They are a specific type of T cells (cell_type)
2. atopic patients | False | atopic patients"" refers to a group of individuals, not a protein, DNA, RNA, Cell Type or Cell Line
3. IL-4-producing Th2 cells | True | IL-4 and Th2 cells are types of proteins and cell types (protein, cell_type) respectively
4. IgE | True | Immunoglobulin E (IgE) is a type of protein (protein)
5. B cells | True | B cells are a type of cell (cell_type)",0.25,"Allergen-specific | B-cell_type T | I-cell_type cells | I-cell_type in | O atopic | O patients | O are | O polarized | O IL-4-producing | B-protein, cell_type Th2 | I-protein, cell_type cells | I-protein, cell_type , | O promoting | O IgE | B-IgE synthesis | O by | O B | B-cell_type cells | I-cell_type . | O","Allergen-specific | O T | B-cell_type cells | I-cell_type in | O atopic | O patients | O are | O polarized | O IL-4-producing | B-cell_line Th2 | I-cell_line cells | I-cell_line , | O promoting | O IgE | B-protein synthesis | O by | O B | B-cell_type cells | I-cell_type . | O",False
Increases in interferon-gamma production and natural killer cell activity in response to IL-18 are abrogated .,"['interferon-gamma', 'IL-18']","['O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O']","['O', 'O', 'B-protein', 'O', 'O', 'B-cell_type', 'I-cell_type', 'I-cell_type', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O']","1. interferon-gamma | True | as it is a protein (protein)
2. natural killer cell | True | as it is a type of cell (cell_type)
3. IL-18 | True | as it is a protein (protein)
4. Increases | False | as it is a process
5. response | False | as it is a process 
6. abrogated | False | as it is an action, not a entity.",0.8,Increases | O in | O interferon-gamma | B-protein production | O and | O natural | B-cell_type killer | I-cell_type cell | I-cell_type activity | O in | O response | O to | O IL-18 | B-protein are | O abrogated | O . | O,Increases | O in | O interferon-gamma | B-protein production | O and | O natural | O killer | O cell | O activity | O in | O response | O to | O IL-18 | B-protein are | O abrogated | O . | O,False
Tyrosine phosphorylation STAT1 or STAT3 was not detected in human erythroid precursors after stimulation with erythropoietin .,"['STAT1', 'STAT3', 'human erythroid precursors', 'erythropoietin']","['O', 'O', 'B-protein', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'I-cell_type', 'O', 'O', 'O', 'B-protein', 'O']","['O', 'O', 'B-protein', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'I-cell_type', 'O', 'O', 'O', 'B-protein', 'O']","1. Tyrosine | False | Tyrosine is an amino acid not a protein, DNA, RNA, Cell Type or Cell Line
2. phosphorylation | False | as it is a process not an entity
3. STAT1 | True | as it is a protein (protein)
4. STAT3 | True | as it is a protein (protein)
5. human erythroid precursors | True | as they are a cell type (cell_type)
6. stimulation | False | as it is a process
7. erythropoietin | True | as it is a protein (protein)",1.0,Tyrosine | O phosphorylation | O STAT1 | B-protein or | O STAT3 | B-protein was | O not | O detected | O in | O human | B-cell_type erythroid | I-cell_type precursors | I-cell_type after | O stimulation | O with | O erythropoietin | B-protein . | O,Tyrosine | O phosphorylation | O STAT1 | B-protein or | O STAT3 | B-protein was | O not | O detected | O in | O human | B-cell_type erythroid | I-cell_type precursors | I-cell_type after | O stimulation | O with | O erythropoietin | B-protein . | O,True
"Altogether , these results suggest that atypical PKC isoenzymes , including PKC-zeta , participate in the signal transduction pathways by which HIV infection results in the activation of NF-kappa B in human monocytic cells and macrophages .","['atypical PKC isoenzymes', 'PKC-zeta', 'NF-kappa B', 'human monocytic cells', 'macrophages']","['O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O', 'B-cell_type', 'I-cell_type', 'I-cell_type', 'O', 'B-cell_type', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'O', 'O', 'B-PKC', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O', 'B-cell_type', 'I-cell_type', 'I-cell_type', 'O', 'B-cell_type', 'O']","1. atypical PKC isoenzymes | True | as they are proteins (protein)
2. PKC-zeta | True | as it is a specific type of atypical protein kinase C (PKC) isoforms (protein)
3. signal transduction pathways | False | as they are biological processes, not entities
4. HIV infection | False | it's an event or a condition but not an entity in itself
5. NF-kappa B | True | it's a protein complex that controls transcription of DNA (protein)
6. human monocytic cells | True | as they are a type of cell (cell_type)
7. macrophages | True | as they are a type of cell (cell_type)",0.8000000000000002,"Altogether | O , | O these | O results | O suggest | O that | O atypical | B-protein PKC | I-protein isoenzymes | I-protein , | O including | O PKC-zeta | B-PKC , | O participate | O in | O the | O signal | O transduction | O pathways | O by | O which | O HIV | O infection | O results | O in | O the | O activation | O of | O NF-kappa | B-protein B | I-protein in | O human | B-cell_type monocytic | I-cell_type cells | I-cell_type and | O macrophages | B-cell_type . | O","Altogether | O , | O these | O results | O suggest | O that | O atypical | B-protein PKC | I-protein isoenzymes | I-protein , | O including | O PKC-zeta | B-protein , | O participate | O in | O the | O signal | O transduction | O pathways | O by | O which | O HIV | O infection | O results | O in | O the | O activation | O of | O NF-kappa | B-protein B | I-protein in | O human | B-cell_type monocytic | I-cell_type cells | I-cell_type and | O macrophages | B-cell_type . | O",False
Activation of the interleukin 2 ( IL-2 ) gene after antigen recognition is a critical event for T cell proliferation and effector function .,['interleukin 2 ( IL-2 ) gene'],"['O', 'O', 'O', 'B-DNA', 'I-DNA', 'I-DNA', 'I-DNA', 'I-DNA', 'I-DNA', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'B-DNA', 'I-DNA', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'O', 'O', 'O', 'O', 'O']","1. interleukin 2 ( IL-2 ) gene | True | as it is a gene or DNA (DNA)
2. antigen | False | as antigen is not an entity category listed.
3. T cell | True | as it is a type of cell (cell_type)
4. proliferation | False | as it is a process
5. effector function | False | as it's not a protein, DNA, RNA, Cell Type or Cell Line.",0.0,Activation | O of | O the | O interleukin | B-DNA 2 | I-DNA ( | O IL-2 | O ) | O gene | O after | O antigen | O recognition | O is | O a | O critical | O event | O for | O T | B-cell_type cell | I-cell_type proliferation | O and | O effector | O function | O . | O,Activation | O of | O the | O interleukin | B-DNA 2 | I-DNA ( | I-DNA IL-2 | I-DNA ) | I-DNA gene | I-DNA after | O antigen | O recognition | O is | O a | O critical | O event | O for | O T | O cell | O proliferation | O and | O effector | O function | O . | O,False
"The prevalence of DNA aneuploidy was 30 % , overexpression of ER 10 % , and overexpression of EGFR 35 % , in the 206 high risk women whose median 10 year Gail risk ( projected probability ) of developing breast cancer was 4.5 % .","['ER', 'EGFR']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'B-DNA', 'I-DNA', 'O', 'O', 'O', 'O', 'O', 'O', 'B-Estrogen Receptor', 'O', 'O', 'O', 'O', 'O', 'O', 'B-Epidermal Growth Factor Receptor', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","1. DNA aneuploidy | True | as it is a condition related to DNA (DNA)
   2. ER | True | as it (Estrogen Receptor) is a protein (protein)
   3. EGFR | True | as it is a protein (Epidermal Growth Factor Receptor) (protein)
   4. high risk women | False | as it denotes a category of affected individuals and not a protein, DNA, RNA, Cell Type or Cell Line
   5. Gail risk | False | as it denotes a risk model and not a protein, DNA, RNA, Cell Type or Cell Line
   6. breast cancer | False | as it is a disease/condition and not a protein, DNA, RNA, Cell Type or Cell Line.",0.0,"The | O prevalence | O of | O DNA | B-DNA aneuploidy | I-DNA was | O 30 | O % | O , | O overexpression | O of | O ER | B-Estrogen Receptor 10 | O % | O , | O and | O overexpression | O of | O EGFR | B-Epidermal Growth Factor Receptor 35 | O % | O , | O in | O the | O 206 | O high | O risk | O women | O whose | O median | O 10 | O year | O Gail | O risk | O ( | O projected | O probability | O ) | O of | O developing | O breast | O cancer | O was | O 4.5 | O % | O . | O","The | O prevalence | O of | O DNA | O aneuploidy | O was | O 30 | O % | O , | O overexpression | O of | O ER | B-protein 10 | O % | O , | O and | O overexpression | O of | O EGFR | B-protein 35 | O % | O , | O in | O the | O 206 | O high | O risk | O women | O whose | O median | O 10 | O year | O Gail | O risk | O ( | O projected | O probability | O ) | O of | O developing | O breast | O cancer | O was | O 4.5 | O % | O . | O",False
"The insertion of multiple copies of the binding site for the former or latter factor into a heterologous promoter reduced the promoter activity to one-tenth or one-third , respectively .","['binding site', 'heterologous promoter']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","1. multiple copies | False | as it is a quantity, not an entity 
2. binding site | False | as it is a location or specific part of an entity, but not an entity itself 
3. former or latter factor | False | as the specific factors are not named or identified
4. heterologous promoter | True | it is a type of promoter and therefore a part of DNA (DNA) 
5. promoter activity | False | as activity refers to a process, not an entity
",0.6666666666666666,"The | O insertion | O of | O multiple | O copies | O of | O the | O binding | O site | O for | O the | O former | O or | O latter | O factor | O into | O a | O heterologous | B-DNA promoter | I-DNA reduced | O the | O promoter | O activity | O to | O one-tenth | O or | O one-third | O , | O respectively | O . | O","The | O insertion | O of | O multiple | O copies | O of | O the | O binding | B-DNA site | I-DNA for | O the | O former | O or | O latter | O factor | O into | O a | O heterologous | B-DNA promoter | I-DNA reduced | O the | O promoter | O activity | O to | O one-tenth | O or | O one-third | O , | O respectively | O . | O",False
We have cloned and characterized a mitogen-inducible gene isolated from human T cells that predicts a protein of 968 amino acids .,"['mitogen-inducible gene', 'human T cells', '968 amino acids']","['O', 'O', 'O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'O', 'O', 'B-cell_type', 'I-cell_type', 'I-cell_type', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'O', 'O', 'B-cell_type', 'I-cell_type', 'I-cell_type', 'O', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'I-protein', 'I-protein', 'O']","1. mitogen-inducible gene | True | as it is a type of gene (DNA)
2. human T cells | True | as they are a type of cell (cell_type)
3. protein of 968 amino acids | True | as it is a protein (protein)",0.6666666666666666,We | O have | O cloned | O and | O characterized | O a | O mitogen-inducible | B-DNA gene | I-DNA isolated | O from | O human | B-cell_type T | I-cell_type cells | I-cell_type that | O predicts | O a | O protein | B-protein of | I-protein 968 | I-protein amino | I-protein acids | I-protein . | O,We | O have | O cloned | O and | O characterized | O a | O mitogen-inducible | B-DNA gene | I-DNA isolated | O from | O human | B-cell_type T | I-cell_type cells | I-cell_type that | O predicts | O a | O protein | O of | O 968 | B-protein amino | I-protein acids | I-protein . | O,False
"In monocytes , the virus was bound to the surface without being internalized .",[],"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'B-cell_type', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","1. monocytes | True | as they are a type of cell (cell_type).
2. virus | False | while it's biological, it's not a protein, DNA, RNA, Cell Type, or Cell Line.",0.0,"In | O monocytes | B-cell_type , | O the | O virus | O was | O bound | O to | O the | O surface | O without | O being | O internalized | O . | O","In | O monocytes | O , | O the | O virus | O was | O bound | O to | O the | O surface | O without | O being | O internalized | O . | O",False
The involvement of ion channels in B and T lymphocyte activation is supported by many reports of changes in ion fluxes and membrane potential after mitogen binding .,['mitogen'],"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O']","['O', 'O', 'O', 'B-protein', 'I-protein', 'O', 'B-cell_type', 'I-cell_type', 'I-cell_type', 'I-cell_type', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O']","1. Ion channels | True | as they are proteins (protein)
2. B and T lymphocyte | True | as they are a type of cell (cell_type)
3. Ion fluxes | False | as they are not a protein, DNA, RNA, Cell Type or Cell Line; they are rather a process.
4. Membrane potential | False | as it is a physical property of cells, not a specific entity or protein.
5. Mitogen | True | because it is a type of protein (protein)",0.5,The | O involvement | O of | O ion | B-protein channels | I-protein in | O B | B-cell_type and | I-cell_type T | I-cell_type lymphocyte | I-cell_type activation | O is | O supported | O by | O many | O reports | O of | O changes | O in | O ion | O fluxes | O and | O membrane | O potential | O after | O mitogen | B-protein binding | O . | O,The | O involvement | O of | O ion | O channels | O in | O B | O and | O T | O lymphocyte | O activation | O is | O supported | O by | O many | O reports | O of | O changes | O in | O ion | O fluxes | O and | O membrane | O potential | O after | O mitogen | B-protein binding | O . | O,False
"CONCLUSION : These data suggest that glucocorticoids such as budesonide , by virtue of their high GCR binding affinities and greater ability to suppress lymphocyte proliferation , may therefore be beneficial in the management of difficult-to-control asthma .",['GCR'],"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B-proteins', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'B-Glucocorticoid receptors', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_type', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","1. glucocorticoids | True | as they are a group of steroid hormones, which in this scenario can be treated as proteins (proteins)
2. budesonide | True | as it is a type of glucocorticoid which is a protein in this context (protein)
3. GCR | True | GCR (Glucocorticoid receptors) are a type of protein (protein)
4. lymphocyte | True | as it is a type of cell (cell_type)
5. asthma | False | as it is a disease and not fitting the protein, DNA, RNA, cell type, or cell line criteria.",0.0,"CONCLUSION | O : | O These | O data | O suggest | O that | O glucocorticoids | B-proteins such | O as | O budesonide | B-protein , | O by | O virtue | O of | O their | O high | O GCR | B-Glucocorticoid receptors binding | O affinities | O and | O greater | O ability | O to | O suppress | O lymphocyte | B-cell_type proliferation | O , | O may | O therefore | O be | O beneficial | O in | O the | O management | O of | O difficult-to-control | O asthma | O . | O","CONCLUSION | O : | O These | O data | O suggest | O that | O glucocorticoids | O such | O as | O budesonide | O , | O by | O virtue | O of | O their | O high | O GCR | B-protein binding | O affinities | O and | O greater | O ability | O to | O suppress | O lymphocyte | O proliferation | O , | O may | O therefore | O be | O beneficial | O in | O the | O management | O of | O difficult-to-control | O asthma | O . | O",False
"Thus , the reduction of CN activity observed in CsA-treated patients is accompanied by a similar degree of reduction in lymphocyte gene activation , and accounts for the immunosuppression observed .","['CN', 'lymphocyte gene']","['O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","1. Reduction | False | as it is a process
        2. CN activity | True | as ""CN"" is an abbreviation for the enzyme calcineurin, it is a protein (protein)
        3. CsA | True |as ""CsA"" is an abbreviation for Cyclosporin A, a drug that affects proteins (protein)
        4. patients | False | as they're individuals, not proteins, DNA, RNA, cell types or cell lines
        5. lymphocyte gene activation | False | it includes a cell type (Lymphocyte), but overall it describes a process thus it is not considered as an entity.
        6. immunosuppression | False | as it is a medical condition, not a protein, DNA, RNA, cell type, or cell line.",0.0,"Thus | O , | O the | O reduction | O of | O CN | B-protein activity | I-protein observed | O in | O CsA-treated | O patients | O is | O accompanied | O by | O a | O similar | O degree | O of | O reduction | O in | O lymphocyte | O gene | O activation | O , | O and | O accounts | O for | O the | O immunosuppression | O observed | O . | O","Thus | O , | O the | O reduction | O of | O CN | B-protein activity | O observed | O in | O CsA-treated | O patients | O is | O accompanied | O by | O a | O similar | O degree | O of | O reduction | O in | O lymphocyte | B-DNA gene | I-DNA activation | O , | O and | O accounts | O for | O the | O immunosuppression | O observed | O . | O",False
"When cloned in multiple copies this so-called TCEd ( distal T cell element ) acts as an inducible proto-enhancer element in E14 T lymphoma cells , but not in HeLa cells .","['TCEd', 'distal T cell element', 'proto-enhancer element', 'E14 T lymphoma cells', 'HeLa cells']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DNA', 'O', 'B-DNA', 'I-DNA', 'I-DNA', 'I-DNA', 'O', 'O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'O', 'B-cell_line', 'I-cell_line', 'I-cell_line', 'I-cell_line', 'O', 'O', 'O', 'O', 'B-cell_line', 'I-cell_line', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'I-DNA', 'I-DNA', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_line', 'I-cell_line', 'I-cell_line', 'I-cell_line', 'O', 'O', 'O', 'O', 'B-cell_line', 'I-cell_line', 'O']","1. Distal T cell element (TCEd) | True | as it refers to a sequence of DNA (DNA)
2. Proto-enhancer element | False | as this refers to a function or role, not a specific entity
3. E14 T lymphoma cells | True | as it refers to a specific cell line (cell_line)
4. HeLa cells | True | as it refers to a specific and well-known cell line (cell_line).",0.7499999999999999,"When | O cloned | O in | O multiple | O copies | O this | O so-called | O TCEd | O ( | O distal | B-DNA T | I-DNA cell | I-DNA element | I-DNA ) | O acts | O as | O an | O inducible | O proto-enhancer | O element | O in | O E14 | B-cell_line T | I-cell_line lymphoma | I-cell_line cells | I-cell_line , | O but | O not | O in | O HeLa | B-cell_line cells | I-cell_line . | O","When | O cloned | O in | O multiple | O copies | O this | O so-called | O TCEd | B-DNA ( | O distal | B-DNA T | I-DNA cell | I-DNA element | I-DNA ) | O acts | O as | O an | O inducible | O proto-enhancer | B-DNA element | I-DNA in | O E14 | B-cell_line T | I-cell_line lymphoma | I-cell_line cells | I-cell_line , | O but | O not | O in | O HeLa | B-cell_line cells | I-cell_line . | O",False
NF-kappa B is a rapidly inducible transcriptional activator that responds to a variety of signals and influences the expression of many genes involved in the immune response .,"['NF-kappa B', 'transcriptional activator']","['B-protein', 'I-protein', 'O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B-protein', 'I-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","1. NF-kappa B | True | This is a protein that acts as a transcriptional activator (protein)
2. Transcriptional activator | False | While it's related to protein function, it is not a protein, cell type, cell line, DNA, or RNA itself, but rather a role or function of certain proteins.
3. Genes | False | While genes are made up of DNA, the term ""genes"" in a general sense doesn't refer to a specific DNA sequence or structure and therefore isn't considered an entity here.
4. Immune response | False | This is a process or system within the body, not a cell type, cell line, protein, DNA, or RNA.",0.6666666666666666,NF-kappa | B-protein B | I-protein is | O a | O rapidly | O inducible | O transcriptional | O activator | O that | O responds | O to | O a | O variety | O of | O signals | O and | O influences | O the | O expression | O of | O many | O genes | O involved | O in | O the | O immune | O response | O . | O,NF-kappa | B-protein B | I-protein is | O a | O rapidly | O inducible | O transcriptional | B-DNA activator | I-DNA that | O responds | O to | O a | O variety | O of | O signals | O and | O influences | O the | O expression | O of | O many | O genes | O involved | O in | O the | O immune | O response | O . | O,False
"Our results imply that T cells need to maintain a certain level of NF-kappaB transcriptional activity in order to survive ; up- or down-regulation of nuclear NF kappaB through modulation of IkappaBalpha expression by cytokines or DEX may lead to cell survival or cell death , respectively .","['T cells', 'NF-kappaB', 'nuclear NF kappaB', 'IkappaBalpha', 'cytokines']","['O', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'B-protein', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","1. T cells | True | as they are a type of cell (cell_type)
2. NF-kappaB | True | as it is a protein transcription factor (protein) 
3. nuclear NF kappaB | True | it is a upstream regulator for many genes therefore it's considered as a protein(protein)
4.  IkappaBalpha | True | as it is a part of proteins in the NF-kappaB protein complex (protein) 
5. cytokines | True | cytokines are a broad category of small proteins that are important in cell signaling (protein)
6. DEX | True | it refers to Dexamethasone, a type of Corticosteroid which affects proteins and can be seen as a substance that affects proteins (protein).
7. cell survival | False | as cell survival is a process, not an entity
8. cell death | False | as cell death is also a process, not an entity.",0.9090909090909092,"Our | O results | O imply | O that | O T | B-cell_type cells | I-cell_type need | O to | O maintain | O a | O certain | O level | O of | O NF-kappaB | B-protein transcriptional | O activity | O in | O order | O to | O survive | O ; | O up- | O or | O down-regulation | O of | O nuclear | B-protein NF | I-protein kappaB | I-protein through | O modulation | O of | O IkappaBalpha | B-protein expression | O by | O cytokines | B-protein or | O DEX | B-protein may | O lead | O to | O cell | O survival | O or | O cell | O death | O , | O respectively | O . | O","Our | O results | O imply | O that | O T | B-cell_type cells | I-cell_type need | O to | O maintain | O a | O certain | O level | O of | O NF-kappaB | B-protein transcriptional | O activity | O in | O order | O to | O survive | O ; | O up- | O or | O down-regulation | O of | O nuclear | B-protein NF | I-protein kappaB | I-protein through | O modulation | O of | O IkappaBalpha | B-protein expression | O by | O cytokines | B-protein or | O DEX | O may | O lead | O to | O cell | O survival | O or | O cell | O death | O , | O respectively | O . | O",False
Our data also demonstrate that NAC increases the GSH-to-GSSG ratio within the EC suggesting one possible mechanism through which this antioxidant inhibits agonist-induced monocyte adhesion to EC .,"['EC', 'EC']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_type', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_type', 'O']","['O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_type', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_type', 'O', 'O', 'O', 'O']","1. NAC | True | As it's N-acetylcysteine, which is a protein (protein)
2. GSH-to-GSSG ratio | False | These are Glutathione in reduced form (GSH) and the oxidized form (GSSG) which while being important in cell metabolism are should not be considered as protein, DNA, RNA, Cell Type or Cell Line.
3. EC | True | If EC refers to endothelial cells, then it is an entity as it is a type of cell (cell_type)
4. agonist-induced monocyte adhesion | False | Despite being a biological process involving monocytes (a cell type), the process itself is not an entity.
5. monocyte | True | Monocytes are a type of white blood cell or leukocyte and should be considered under cell type (cell_type) 
6. antioxidant | False | It is a type or property of some compounds, which prevent oxidation - it's neither protein, DNA, RNA, Cell Type, nor Cell Line.",0.4,Our | O data | O also | O demonstrate | O that | O NAC | B-protein increases | O the | O GSH-to-GSSG | O ratio | O within | O the | O EC | B-cell_type suggesting | O one | O possible | O mechanism | O through | O which | O this | O antioxidant | O inhibits | O agonist-induced | O monocyte | B-cell_type adhesion | O to | O EC | O . | O,Our | O data | O also | O demonstrate | O that | O NAC | O increases | O the | O GSH-to-GSSG | O ratio | O within | O the | O EC | B-cell_type suggesting | O one | O possible | O mechanism | O through | O which | O this | O antioxidant | O inhibits | O agonist-induced | O monocyte | O adhesion | O to | O EC | B-cell_type . | O,False
"Rhom-2 mRNA is expressed in early mouse development in central nervous system , lung , kidney , liver , and spleen but only very low levels occur in thymus .",['Rhom-2 mRNA'],"['B-RNA', 'I-RNA', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B-RNA', 'I-RNA', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'I-cell_type', 'O', 'B-cell_type', 'O', 'B-cell_type', 'O', 'B-cell_type', 'O', 'O', 'B-cell_type', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_type', 'O']","1. Rhom-2 mRNA | True | as it is a type of RNA (RNA)
2. mouse | False | as it is an organism, not protein, DNA, RNA, Cell Type or Cell Line
3. development | False | as it is a process 
4. central nervous system | True | as it is a type of cell grouping (cell_type)
5. lung | True | as it is a type of cell grouping (cell_type)
6. kidney | True | as it is a type of cell grouping (cell_type)
7. liver | True | as it is a type of cell grouping (cell_type)
8. spleen | True | as it is a type of cell grouping (cell_type)
9. thymus | True | as it is a type of cell grouping (cell_type)",0.25,"Rhom-2 | B-RNA mRNA | I-RNA is | O expressed | O in | O early | O mouse | O development | O in | O central | B-cell_type nervous | I-cell_type system | I-cell_type , | O lung | B-cell_type , | O kidney | B-cell_type , | O liver | B-cell_type , | O and | O spleen | B-cell_type but | O only | O very | O low | O levels | O occur | O in | O thymus | B-cell_type . | O","Rhom-2 | B-RNA mRNA | I-RNA is | O expressed | O in | O early | O mouse | O development | O in | O central | O nervous | O system | O , | O lung | O , | O kidney | O , | O liver | O , | O and | O spleen | O but | O only | O very | O low | O levels | O occur | O in | O thymus | O . | O",False
"gamma-Interferon -induced resistance to 1 , 25- ( OH ) 2 D3 in human monocytes and macrophages : a mechanism for the hypercalcemia of various granulomatoses .","['gamma-Interferon', 'human monocytes', 'macrophages']","['B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'O', 'B-cell_type', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'O', 'B-cell_type', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","1. gamma-Interferon | True | as it is a type of protein (protein)
        2. 1 , 25- ( OH ) 2 D3 | False | as it is a vitamin, not a protein, DNA, RNA, Cell Type or Cell Line
        3. human monocytes | True | as they are a type of cell (cell_type)
        4. macrophages | True | as they are a type of cell (cell_type)
        5. hypercalcemia | False | as it is a condition, not a protein, DNA, RNA, Cell Type or Cell Line
        6. various granulomatoses | False | as it is a disease condition, not a protein, DNA, RNA, Cell Type or Cell Line.",1.0,"gamma-Interferon | B-protein -induced | O resistance | O to | O 1 | O , | O 25- | O ( | O OH | O ) | O 2 | O D3 | O in | O human | B-cell_type monocytes | I-cell_type and | O macrophages | B-cell_type : | O a | O mechanism | O for | O the | O hypercalcemia | O of | O various | O granulomatoses | O . | O","gamma-Interferon | B-protein -induced | O resistance | O to | O 1 | O , | O 25- | O ( | O OH | O ) | O 2 | O D3 | O in | O human | B-cell_type monocytes | I-cell_type and | O macrophages | B-cell_type : | O a | O mechanism | O for | O the | O hypercalcemia | O of | O various | O granulomatoses | O . | O",True
"In a cotransfection assay , the Tax protein of both HTLV-I and HTLV-II specifically activated transcription from the IL-1alpha promoter in an uninfected Jurkat cell line .","['Tax protein', 'IL-1alpha promoter', 'uninfected Jurkat cell line']","['O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'O', 'O', 'B-cell_line', 'I-cell_line', 'I-cell_line', 'I-cell_line', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'O', 'O', 'B-RNA', 'I-RNA', 'I-RNA', 'O', 'O', 'O', 'O', 'O', 'B-DNA', 'I-DNA', 'O', 'O', 'B-cell_line', 'I-cell_line', 'I-cell_line', 'I-cell_line', 'O']","1. cotransfection assay | False | as it is a technique or process 
2. Tax protein | True | it is a protein (protein) 
3. HTLV-I and HTLV-II | True | these are human T-cell leukemia viruses, considered as entities belonging to the RNA viruses class (RNA)
4. transcription | False | as it refers to a process
5. IL-1alpha promoter | True | as it is a part of DNA (DNA)
6. uninfected Jurkat cell line | True | referring to Jurkat, which is a type of a cell line (cell_line)",0.8571428571428571,"In | O a | O cotransfection | O assay | O , | O the | O Tax | B-protein protein | I-protein of | O both | O HTLV-I | B-RNA and | I-RNA HTLV-II | I-RNA specifically | O activated | O transcription | O from | O the | O IL-1alpha | B-DNA promoter | I-DNA in | O an | O uninfected | B-cell_line Jurkat | I-cell_line cell | I-cell_line line | I-cell_line . | O","In | O a | O cotransfection | O assay | O , | O the | O Tax | B-protein protein | I-protein of | O both | O HTLV-I | O and | O HTLV-II | O specifically | O activated | O transcription | O from | O the | O IL-1alpha | B-DNA promoter | I-DNA in | O an | O uninfected | B-cell_line Jurkat | I-cell_line cell | I-cell_line line | I-cell_line . | O",False
"Furthermore , PU.1 transactivates the M-CSF receptor promoter in nonmacrophage cells .","['PU.1', 'M-CSF receptor promoter', 'nonmacrophage cells']","['O', 'O', 'B-protein', 'O', 'O', 'B-DNA', 'I-DNA', 'I-DNA', 'O', 'B-cell_type', 'I-cell_type', 'O']","['O', 'O', 'B-protein', 'O', 'O', 'B-DNA', 'I-DNA', 'I-DNA', 'O', 'B-cell_type', 'I-cell_type', 'O']","1. PU.1 | True | as it is a transcription factor which is a type of protein (protein)
        2. M-CSF receptor promoter | True | as it is a section of DNA that initiates transcription of a particular gene (DNA)
        3. nonmacrophage cells | True | as they are a type of cell (cell_type)",1.0,"Furthermore | O , | O PU.1 | B-protein transactivates | O the | O M-CSF | B-DNA receptor | I-DNA promoter | I-DNA in | O nonmacrophage | B-cell_type cells | I-cell_type . | O","Furthermore | O , | O PU.1 | B-protein transactivates | O the | O M-CSF | B-DNA receptor | I-DNA promoter | I-DNA in | O nonmacrophage | B-cell_type cells | I-cell_type . | O",True
"125I-IL-13 did not bind to colon cancer cell lines , but unlabeled IL-13 competed for the binding of 125I-IL-4 .","['125I-IL-13', 'colon cancer cell lines', 'IL-13', '125I-IL-4']","['B-protein', 'O', 'O', 'O', 'O', 'B-cell_line', 'I-cell_line', 'I-cell_line', 'I-cell_line', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O']","['B-protein', 'O', 'O', 'O', 'O', 'B-cell_line', 'I-cell_line', 'I-cell_line', 'I-cell_line', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O']","1. 125I-IL-13 | True | it is a labeled version of the protein IL-13 (protein).
2. colon cancer cell lines | True | it refers to specific types of cells that have been derived from colon cancer tissue (cell_line).
3. IL-13 | True | it is an interleukin, a type of protein (protein).
4. binding | False | it is a process, not an entity.
5. 125I-IL-4 | True | it is a labeled version of the protein IL-4 (protein).
6. IL-4 | True | it is known as interleukin 4, which is a kind of protein (protein).",1.0,"125I-IL-13 | B-protein did | O not | O bind | O to | O colon | B-cell_line cancer | I-cell_line cell | I-cell_line lines | I-cell_line , | O but | O unlabeled | O IL-13 | B-protein competed | O for | O the | O binding | O of | O 125I-IL-4 | B-protein . | O","125I-IL-13 | B-protein did | O not | O bind | O to | O colon | B-cell_line cancer | I-cell_line cell | I-cell_line lines | I-cell_line , | O but | O unlabeled | O IL-13 | B-protein competed | O for | O the | O binding | O of | O 125I-IL-4 | B-protein . | O",True
One family of host transcription factors whose activity is altered by Tax includes NF-kappa B/Rel .,"['host transcription factors', 'Tax', 'NF-kappa B/Rel']","['O', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'B-protein', 'I-protein', 'O']","['O', 'B-protein', 'I-protein', 'I-protein', 'I-protein', 'I-protein', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'B-protein', 'I-protein', 'O']","1. family of host transcription factors | True | as they are a group of proteins (protein)
2. Tax | True | as it is a protein (protein)
3. NF-kappa B/Rel | True | they are proteins (protein)",0.6666666666666666,One | O family | B-protein of | I-protein host | I-protein transcription | I-protein factors | I-protein whose | O activity | O is | O altered | O by | O Tax | B-protein includes | O NF-kappa | B-protein B/Rel | I-protein . | O,One | O family | O of | O host | B-protein transcription | I-protein factors | I-protein whose | O activity | O is | O altered | O by | O Tax | B-protein includes | O NF-kappa | B-protein B/Rel | I-protein . | O,False
"The adenoviral technique described here has widespread applicability , allowing rapid testing of the effects of blocking a potential therapeutic target in either cultures of normal cells or in the diseased tissue itself .",['normal cells'],"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","1. adenoviral technique | False | as it is a method, not a protein, DNA, RNA, Cell Type or Cell Line
    2. normal cells | False | it is too general, to be considered a specific cell type (cell_type)
    3. diseased tissue | False | 'diseased tissue' is a general term that can encompass a wide variety of specific cell types and does not meet the criteria.",0.0,"The | O adenoviral | O technique | O described | O here | O has | O widespread | O applicability | O , | O allowing | O rapid | O testing | O of | O the | O effects | O of | O blocking | O a | O potential | O therapeutic | O target | O in | O either | O cultures | O of | O normal | O cells | O or | O in | O the | O diseased | O tissue | O itself | O . | O","The | O adenoviral | O technique | O described | O here | O has | O widespread | O applicability | O , | O allowing | O rapid | O testing | O of | O the | O effects | O of | O blocking | O a | O potential | O therapeutic | O target | O in | O either | O cultures | O of | O normal | B-cell_type cells | I-cell_type or | O in | O the | O diseased | O tissue | O itself | O . | O",False
"Like in Th2 clones , suppressed NFAT- P0 complex formation was observed also at the polyclonal level in peripheral blood mononuclear cells ( PBMC ) of three of five severe atopic dermatitis patients with strongly elevated serum IgE levels , but not in control PBMC .","['Th2 clones', 'P0', 'peripheral blood mononuclear cells', 'PBMC', 'IgE', 'PBMC']","['O', 'O', 'B-cell_line', 'I-cell_line', 'O', 'O', 'O', 'B-DNA', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'I-cell_type', 'I-cell_type', 'O', 'B-cell_type', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_type', 'O']","['O', 'O', 'B-cell_line', 'I-cell_line', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'I-cell_type', 'I-cell_type', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-cell_type', 'I-cell_type', 'O']","1. Th2 clones | True | They're a type of cell line (cell_line).
2. NFAT- P0 complex | True | This is a reference to a protein or protein complex (protein).
3. polyclonal level | False | This is an abstract concept, not an entity.
4. peripheral blood mononuclear cells ( PBMC ) | True | This is a term for a specific type of cell (cell_type).
5. severe atopic dermatitis | False | This is a disease, not a protein, group of proteins, DNA, RNA, cell type or cell line.
6. serum IgE levels | False | Although IgE is a protein, ""serum IgE levels"" refers to the measurement or quantity, not the protein itself.
7. control PBMC | True | This is another reference to peripheral blood mononuclear cells, a specific cell type (cell_type).",0.4,"Like | O in | O Th2 | B-cell_line clones | I-cell_line , | O suppressed | O NFAT- | B-protein P0 | I-protein complex | I-protein formation | O was | O observed | O also | O at | O the | O polyclonal | O level | O in | O peripheral | B-cell_type blood | I-cell_type mononuclear | I-cell_type cells | I-cell_type ( | O PBMC | O ) | O of | O three | O of | O five | O severe | O atopic | O dermatitis | O patients | O with | O strongly | O elevated | O serum | O IgE | O levels | O , | O but | O not | O in | O control | B-cell_type PBMC | I-cell_type . | O","Like | O in | O Th2 | B-cell_line clones | I-cell_line , | O suppressed | O NFAT- | O P0 | B-DNA complex | O formation | O was | O observed | O also | O at | O the | O polyclonal | O level | O in | O peripheral | B-cell_type blood | I-cell_type mononuclear | I-cell_type cells | I-cell_type ( | O PBMC | B-cell_type ) | O of | O three | O of | O five | O severe | O atopic | O dermatitis | O patients | O with | O strongly | O elevated | O serum | O IgE | B-protein levels | O , | O but | O not | O in | O control | O PBMC | B-cell_type . | O",False
Viral gene expression was assayed by the level of p24 gag protein released from cultures transfected with the proviral constructs .,['p24 gag protein'],"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","['B-DNA', 'I-DNA', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-protein', 'I-protein', 'I-protein', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']","1. Viral gene | True | as 'Viral gene' is related to DNA (DNA)
2. Expression | False | as it is a process
3. p24 gag protein | True | as it is a protein (protein)
4. Cultures | False | as it doesn't refer to a specific cell type or cell line
5. proviral constructs | False | as it pertains to a method/tool used in genetic research, but not a cell line, cell type, protein, DNA, or RNA.",0.6666666666666666,Viral | B-DNA gene | I-DNA expression | O was | O assayed | O by | O the | O level | O of | O p24 | B-protein gag | I-protein protein | I-protein released | O from | O cultures | O transfected | O with | O the | O proviral | O constructs | O . | O,Viral | O gene | O expression | O was | O assayed | O by | O the | O level | O of | O p24 | B-protein gag | I-protein protein | I-protein released | O from | O cultures | O transfected | O with | O the | O proviral | O constructs | O . | O,False
